https://vfhk.org/en 2026-08-19T13:12:48+02:00 daily 1.0 https://vfhk.org/da 2026-08-19T13:12:48+02:00 daily 1.0 https://vfhk.org/en/employee/jakob-heydenreich 2021-10-27T14:32:45+02:00 0.5 https://vfhk.org/da/medarbejder/jakob-heydenreich 2021-10-27T14:32:45+02:00 0.5 https://vfhk.org/en/employee/catharina-margrethe-lerche 2026-06-09T23:00:39+02:00 0.5 https://vfhk.org/da/medarbejder/catharina-margrethe-lerche 2026-06-09T23:00:39+02:00 0.5 https://vfhk.org/en/employee/celina-pihl 2024-10-16T16:36:09+02:00 0.5 https://vfhk.org/da/medarbejder/celina-pihl 2024-10-16T16:36:09+02:00 0.5 https://vfhk.org/en/employee/diana-hoeg 2023-07-27T09:46:38+02:00 0.5 https://vfhk.org/da/medarbejder/diana-hoeeg 2023-07-27T09:46:38+02:00 0.5 https://vfhk.org/en/employee/flemming-andersen 2022-10-26T18:58:50+02:00 0.5 https://vfhk.org/da/medarbejder/flemming-andersen 2022-10-26T18:58:50+02:00 0.5 https://vfhk.org/en/employee/gabriela-llado-grove 2025-06-08T12:46:27+02:00 0.5 https://vfhk.org/da/medarbejder/gabriela-llado-grove 2025-06-08T12:46:27+02:00 0.5 https://vfhk.org/en/employee/katrine-elisabeth-karmisholt 2022-10-26T19:30:34+02:00 0.5 https://vfhk.org/da/medarbejder/katrine-elisabeth-karmisholt 2022-10-26T19:30:34+02:00 0.5 https://vfhk.org/en/employee/katrine-togsverd-bo 2025-01-30T14:20:10+01:00 0.5 https://vfhk.org/da/medarbejder/katrine-togsverd-bo 2025-01-30T14:20:10+01:00 0.5 https://vfhk.org/en/medarbejder/vinzent-kevin-ortner 2025-10-28T13:15:26+01:00 0.5 https://vfhk.org/da/medarbejder/vinzent-kevin-ortner 2025-10-28T13:15:26+01:00 0.5 https://vfhk.org/en/employee/lauritz-falkow-brorsen 2024-12-18T15:48:17+01:00 0.5 https://vfhk.org/da/medarbejder/lauritz-falkow-brorsen 2024-12-18T15:48:17+01:00 0.5 https://vfhk.org/en/employee/martin-glud 2022-02-22T20:48:01+01:00 0.5 https://vfhk.org/da/medarbejder/martin-glud 2022-02-22T20:48:01+01:00 0.5 https://vfhk.org/en/employee/peter-bjerring 2022-12-01T08:47:41+01:00 0.5 https://vfhk.org/da/medarbejder/peter-bjerring 2022-12-01T08:47:41+01:00 0.5 https://vfhk.org/en/employee/peter-alshede-philipsen 2024-01-25T10:50:01+01:00 0.5 https://vfhk.org/da/medarbejder/peter-alshede-philipsen 2024-01-25T10:50:01+01:00 0.5 https://vfhk.org/en/employee/silje-haukali-omland 2022-05-17T14:39:57+02:00 0.5 https://vfhk.org/da/medarbejder/silje-haukali-omland 2022-05-17T14:39:57+02:00 0.5 https://vfhk.org/en/employee/steffen-bjorn-petersen 2022-10-26T19:51:11+02:00 0.5 https://vfhk.org/da/medarbejder/steffen-bjoern-petersen 2022-10-26T19:51:11+02:00 0.5 https://vfhk.org/en/employee/stine-regin-wiegell 2022-11-15T15:10:37+01:00 0.5 https://vfhk.org/da/medarbejder/stine-regin-wiegell 2022-11-15T15:10:37+01:00 0.5 https://vfhk.org/en/employee/uffe-hogh-olesen 2021-10-21T14:43:51+02:00 0.5 https://vfhk.org/da/medarbejder/uffe-hoegh-olesen 2021-10-21T14:43:51+02:00 0.5 https://vfhk.org/en/employee/anette-fejerskov 2022-01-24T11:48:22+01:00 0.5 https://vfhk.org/da/medarbejder/anette-fejerskov 2022-01-24T11:48:22+01:00 0.5 https://vfhk.org/en/employee/lene-rask 2025-04-30T22:49:08+02:00 0.5 https://vfhk.org/da/medarbejder/lene-rask 2025-04-30T22:49:08+02:00 0.5 https://vfhk.org/en/employee/merete-haedersdal 2023-02-21T14:27:50+01:00 0.5 https://vfhk.org/da/medarbejder/merete-haedersdal 2023-02-21T14:27:50+01:00 0.5 https://vfhk.org/en/employee/jeanne-frid 2021-10-27T14:33:27+02:00 0.5 https://vfhk.org/da/medarbejder/jeanne-frid 2021-10-27T14:33:27+02:00 0.5 https://vfhk.org/en/medarbejder/emily-wenande 2025-06-05T14:52:21+02:00 0.5 https://vfhk.org/da/medarbejder/emily-wenande 2025-06-05T14:52:21+02:00 0.5 https://vfhk.org/en/medarbejder/kevin-jacobsen 2026-02-04T09:44:18+01:00 0.5 https://vfhk.org/da/medarbejder/kevin-jacobsen 2026-02-04T09:44:18+01:00 0.5 https://vfhk.org/en/employee/helle-kiellberg-larsen 2022-10-26T16:47:24+02:00 0.5 https://vfhk.org/da/medarbejder/helle-kiellberg-larsen 2022-10-26T16:47:24+02:00 0.5 https://vfhk.org/en/employee/jonatan-riber-granborg 2022-10-26T19:29:16+02:00 0.5 https://vfhk.org/da/medarbejder/jonatan-riber-granborg 2022-10-26T19:29:16+02:00 0.5 https://vfhk.org/en/employee/susanne-kruger-kjaer 2022-10-26T19:52:28+02:00 0.5 https://vfhk.org/da/medarbejder/susanne-kruger-kjaer 2022-10-26T19:52:28+02:00 0.5 https://vfhk.org/en/employee/alexander-egeberg 2024-05-14T09:32:27+02:00 0.5 https://vfhk.org/da/medarbejder/alexander-egeberg 2024-05-14T09:32:27+02:00 0.5 https://vfhk.org/en/medarbejder/johan-sieborg 2026-08-19T13:03:41+02:00 0.5 https://vfhk.org/da/medarbejder/johan-sieborg 2026-08-19T13:03:41+02:00 0.5 https://vfhk.org/en/employee/benedikte-maria-skov 2023-11-14T09:48:58+01:00 0.5 https://vfhk.org/da/medarbejder/benedikte-maria-skov 2023-11-14T09:48:58+01:00 0.5 https://vfhk.org/en/employee/nynne-johanne-sahl-frederiksen 2023-05-09T15:09:25+02:00 0.5 https://vfhk.org/da/medarbejder/nynne-johanne-sahl-frederiksen 2023-05-09T15:09:25+02:00 0.5 https://vfhk.org/en/medarbejder/gabrielle-randskov-vinding 2025-06-05T14:55:45+02:00 0.5 https://vfhk.org/da/medarbejder/gabrielle-randskov-vinding 2025-06-05T14:55:45+02:00 0.5 https://vfhk.org/en/employee/ulrikke-lei 2023-05-02T08:52:57+02:00 0.5 https://vfhk.org/da/medarbejder/ulrikke-lei 2023-05-02T08:52:57+02:00 0.5 https://vfhk.org/en/employee/catrine-fischer-goldschmidt 2023-08-08T11:00:22+02:00 0.5 https://vfhk.org/da/medarbejder/catrine-fischer-goldschmidt 2023-08-08T11:00:22+02:00 0.5 https://vfhk.org/en/employee/gorm-reedtz 2023-08-17T09:30:39+02:00 0.5 https://vfhk.org/da/medarbejder/gorm-reedtz 2023-08-17T09:30:39+02:00 0.5 https://vfhk.org/en/medarbejder/gavrielle-untracht 2025-06-05T14:51:32+02:00 0.5 https://vfhk.org/da/medarbejder/gavrielle-untracht 2025-06-05T14:51:32+02:00 0.5 https://vfhk.org/en/employee/emilie-westerlin-kjeldsen 2024-06-04T08:38:07+02:00 0.5 https://vfhk.org/da/medarbejder/emilie-westerlin-kjeldsen 2024-06-04T08:38:07+02:00 0.5 https://vfhk.org/en/employee/lene-krol-andersen 2024-09-18T16:01:50+02:00 0.5 https://vfhk.org/da/medarbejder/lene-kroel-andersen 2024-09-18T16:01:50+02:00 0.5 https://vfhk.org/en/medarbejder/henrik-solvsten 2025-06-11T15:42:33+02:00 0.5 https://vfhk.org/da/medarbejder/henrik-soelvsten 2025-06-11T15:42:33+02:00 0.5 https://vfhk.org/en/medarbejder/otto-dideriksen 2026-08-19T13:05:43+02:00 0.5 https://vfhk.org/da/medarbejder/otto-dideriksen 2026-08-19T13:05:43+02:00 0.5 https://vfhk.org/en/medarbejder/aqella-rasul 2026-08-19T12:58:19+02:00 0.5 https://vfhk.org/da/medarbejder/aqella-rasul 2026-08-19T12:58:19+02:00 0.5 https://vfhk.org/en/medarbejder/karen-l-larsen 2026-02-25T13:38:43+01:00 0.5 https://vfhk.org/da/medarbejder/karen-l-larsen 2026-02-25T13:38:43+01:00 0.5 https://vfhk.org/en/medarbejder/katja-naasunnguaq-jagd 2026-01-28T11:41:17+01:00 0.5 https://vfhk.org/da/medarbejder/katja-naasunnguaq-jagd 2026-01-28T11:41:17+01:00 0.5 https://vfhk.org/en/medarbejder/beatrice-dyring-andersen 2026-05-05T12:37:34+02:00 0.5 https://vfhk.org/da/medarbejder/beatrice-dyring-andersen 2026-05-05T12:37:34+02:00 0.5 https://vfhk.org/en/medarbejder/sara-karoline-saunte 2026-08-19T13:11:38+02:00 0.5 https://vfhk.org/da/medarbejder/sara-karoline-saunte 2026-08-19T13:11:38+02:00 0.5 https://vfhk.org/en/medarbejder/emilie-sylvestersen-ravn 2026-06-23T09:58:12+02:00 0.5 https://vfhk.org/da/medarbejder/emilie-sylvestersen-ravn 2026-06-23T09:58:12+02:00 0.5 https://vfhk.org/da/event/mennesker-med-hudkraeft-paa-sygehus-personale-paa-sygehuse 2021-05-25T21:32:58+02:00 0.5 https://vfhk.org/da/begivenhed/udviklingshaemning-og-hudkraeft-opsporing-og-udredning 2021-06-29T12:00:12+02:00 0.5 https://vfhk.org/da/event/southern-flounder-popeye-catafula-black-scabbardfish-test 2021-06-07T11:23:49+02:00 0.5 https://vfhk.org/en/landing/collaborating-combat-skin-cancer-denmarks-most-common-cancer-type 2026-08-19T13:12:48+02:00 0.5 https://vfhk.org/da/landing/videncenter-hudkraeft 2026-08-19T13:12:48+02:00 0.5 https://vfhk.org/en/landing/team 2022-04-11T19:43:19+02:00 0.5 https://vfhk.org/da/landing/team 2022-04-11T19:43:19+02:00 0.5 https://vfhk.org/en/landing/publications 2023-08-17T10:54:00+02:00 0.5 https://vfhk.org/da/landing/publikationer 2023-08-17T10:54:00+02:00 0.5 https://vfhk.org/en/landing/research 2025-10-17T14:21:08+02:00 0.5 https://vfhk.org/da/landing/forskning 2025-10-17T14:21:08+02:00 0.5 https://vfhk.org/en/landing/search 2022-02-21T11:21:20+01:00 0.5 https://vfhk.org/da/landing/soeg 2022-02-21T11:21:20+01:00 0.5 https://vfhk.org/en/landing/news 2022-03-04T12:01:52+01:00 0.5 https://vfhk.org/da/landing/nyheder 2022-03-04T12:01:52+01:00 0.5 https://vfhk.org/en/landing/research-projects 2023-08-17T10:47:50+02:00 0.5 https://vfhk.org/da/landing/forskningsprojekter 2023-08-17T10:47:50+02:00 0.5 https://vfhk.org/da/landing/videoer 2023-09-19T11:07:54+02:00 0.5 https://vfhk.org/da/nyhed/videncenter-hudkraeft-lancerer-ny-hjemmeside 2025-08-26T13:48:31+02:00 0.5 https://vfhk.org/en/news/danish-research-center-skin-cancer-launches-homepage 2022-05-09T11:34:59+02:00 0.5 https://vfhk.org/en/news/help-us-develop-better-treatment-options-skin-cancer-patients 2023-08-29T15:10:19+02:00 0.5 https://vfhk.org/da/nyhed/hjaelp-os-til-udvikle-endnu-bedre-behandlinger-af-hudkraeft 2023-08-29T15:10:19+02:00 0.5 https://vfhk.org/en/news/new-research-initiative-takes-human-papillomavirus-hpv-and-skin-cancer-organ-transplant 2023-08-29T15:09:25+02:00 0.5 https://vfhk.org/da/nyhed/nyt-forskningsprojekt-saetter-fokus-paa-hpv-og-hudkraeft-hos-organtransplanterede-patienter 2023-08-29T15:09:25+02:00 0.5 https://vfhk.org/en/news/new-danish-data-systemic-photoprotection-shared-international-scientists 2022-11-03T15:02:16+01:00 0.5 https://vfhk.org/da/nyhed/nye-danske-data-om-systemisk-fotobeskyttelse-delt-paa-international-konference 2022-11-03T15:02:16+01:00 0.5 https://vfhk.org/en/news/new-trial-treating-actinic-keratosis-hpv-vaccines 2023-08-29T15:11:02+02:00 0.5 https://vfhk.org/da/nyhed/nyt-forsoegsstudie-behandling-af-aktinisk-keratose-med-hpv-vacciner 2023-08-29T15:11:02+02:00 0.5 https://vfhk.org/en/news/danish-research-centre-skin-cancer-was-well-represented-recently-held-mass-spectrometry 2022-11-03T14:56:32+01:00 0.5 https://vfhk.org/da/nyhed/videncenter-hudkraeft-var-flot-repraesenteret-paa-den-nyligt-afholdte-massespektrometri 2022-11-03T14:56:32+01:00 0.5 https://vfhk.org/en/news/winner-poster-competition-molecular-fingerprint-skin-cells-could-become-basis-future-treatment 2022-11-03T14:51:08+01:00 0.5 https://vfhk.org/da/nyhed/vinder-af-poster-konkurrence-hudcellers-molekylaere-fingeraftryk-kan-blive-grundlaget 2022-11-03T14:51:08+01:00 0.5 https://vfhk.org/en/news/phd-studies-department-dermatology-supported-innovation-fund-denmark-culminate-excellent 2022-11-03T14:55:08+01:00 0.5 https://vfhk.org/da/nyhed/phd-studier-paa-dermatologisk-afdeling-stoettet-af-innovationsfonden-kulminerer-med-flot 2022-11-03T14:55:08+01:00 0.5 https://vfhk.org/en/news/new-national-guideline-treatment-organ-transplant-patients-skin-cancer-published-ensure-high 2023-04-11T10:31:27+02:00 0.5 https://vfhk.org/da/nyhed/ny-national-retningslinje-behandling-af-organtransplanterede-patienter-med-hudkraeft-skal 2023-04-11T10:31:27+02:00 0.5 https://vfhk.org/en/news/recently-held-photobiology-conference-albuquerque-danish-research-centre-skin-cancer-was-well 2022-11-03T14:50:00+01:00 0.5 https://vfhk.org/da/nyhed/paa-den-nyligt-afholdte-fotobiologi-konference-i-albuquerque-var-videncenter-hudkraeft 2022-11-03T14:50:00+01:00 0.5 https://vfhk.org/en/news/research-stay-boston-phd-student-danish-research-center-skin-cancer-studies-new-strategies 2023-04-11T10:30:38+02:00 0.5 https://vfhk.org/da/nyhed/forskningsophold-i-usa-phd-studerende-fra-videncenter-hudkraeft-forsker-i-nye-strategier 2023-04-11T10:30:38+02:00 0.5 https://vfhk.org/en/news/danish-research-center-skin-cancer-now-instagram-follow-weekly-updates-our-work-and-research 2023-04-11T10:30:02+02:00 0.5 https://vfhk.org/da/nyhed/videncenter-hudkraeft-er-nu-kommet-paa-instagram-foelg-med-i-vores-daglige-arbejde-med 2023-04-11T10:30:02+02:00 0.5 https://vfhk.org/en/news/professor-merete-haedersdal-receives-prestigious-leon-goldman-memorial-award-2023 2023-04-11T10:29:23+02:00 0.5 https://vfhk.org/da/nyhed/professor-merete-haedersdal-modtager-den-prestigefyldte-leon-goldman-memorial-award-2023 2023-04-11T10:29:23+02:00 0.5 https://vfhk.org/en/news/we-wish-all-our-employees-partners-and-followers-merry-christmas 2024-03-14T09:18:18+01:00 0.5 https://vfhk.org/da/nyhed/videncenter-hudkraeft-oensker-medarbejdere-samarbejdspartnere-og-foelgere-en-glaedelig-jul 2024-03-14T09:18:18+01:00 0.5 https://vfhk.org/en/news/how-do-you-increase-repair-dna-damage-associated-skin-cancer-celina-pihl-researches-question 2023-04-11T10:28:35+02:00 0.5 https://vfhk.org/da/nyhed/hvordan-kan-reparation-af-dna-skader-forbundet-med-hudkraeft-oeges-det-spoergsmaal 2023-04-11T10:28:35+02:00 0.5 https://vfhk.org/en/news/moment-joy-halfway-through-vaxak-trial 2023-04-11T10:28:05+02:00 0.5 https://vfhk.org/da/nyhed/stor-glaede-i-vaxak-forsoeget-nu-er-vi-halvvejs 2023-04-11T10:28:05+02:00 0.5 https://vfhk.org/en/news/can-dna-damage-sun-exposure-be-measured-your-urine-after-being-away-sun-holiday 2023-04-11T10:27:35+02:00 0.5 https://vfhk.org/da/nyhed/kan-dna-skader-fra-solens-straaler-maales-i-din-urin-naar-du-kommer-hjem-fra-solferie 2023-04-11T10:27:35+02:00 0.5 https://vfhk.org/en/news/new-study-looking-find-best-skin-cancer-treatment-using-patient-data 2023-05-02T13:05:33+02:00 0.5 https://vfhk.org/da/nyhed/nyt-studie-vil-finde-frem-til-den-bedste-hudkraeftbehandling-ved-hjaelp-af-patientdata 2023-05-02T13:05:33+02:00 0.5 https://vfhk.org/en/news/actinic-keratosis-red-flag-organ-transplant-recipients 2023-04-13T11:17:43+02:00 0.5 https://vfhk.org/da/nyhed/hudmarkoer-til-identifikation-af-organtransplanterede-patienters-hudkraeftrisiko 2023-04-13T11:17:43+02:00 0.5 https://vfhk.org/en/news/better-skin-cancer-detection-exploring-new-innovative-methods 2023-05-16T14:04:38+02:00 0.5 https://vfhk.org/da/nyhed/bedre-identifikation-af-hudkraeft-nye-metoder-skal-i-brug 2023-05-16T14:04:38+02:00 0.5 https://vfhk.org/en/news/enhancing-treatment-effectiveness-actinic-keratosis-patients-breakthrough-study 2023-06-22T11:25:33+02:00 0.5 https://vfhk.org/da/nyhed/nyt-studie-viser-vejen-forbedret-behandling-til-patienter-med-forstadier-til-hudkraeft 2023-06-22T11:25:33+02:00 0.5 https://vfhk.org/en/news/can-we-train-immune-system-combat-skin-cancer 2023-08-15T14:18:07+02:00 0.5 https://vfhk.org/da/nyhed/kan-kroppens-immunforsvar-traenes-til-bekaempe-hudkraeft 2023-08-15T14:18:07+02:00 0.5 https://vfhk.org/en/news/non-invasive-diagnosis-skin-cancer-joint-meeting-cindis-project-and-mva-oncology-network 2023-08-24T11:07:58+02:00 0.5 https://vfhk.org/da/nyhed/symposium-om-nye-ikke-invasive-metoder-til-diagnosticering-af-hudkraeft 2023-08-24T11:07:58+02:00 0.5 https://vfhk.org/en/news/impact-uv-radiation-skin-international-congress-focuses-latest-research 2023-09-05T09:26:55+02:00 0.5 https://vfhk.org/da/nyhed/uv-straalings-paavirkning-af-huden-international-kongres-saetter-fokus-paa-nyeste-forskning 2023-09-05T09:26:55+02:00 0.5 https://vfhk.org/en/news/collaborative-research-efforts-transforming-skin-cancer-care-denmark 2025-08-26T14:33:09+02:00 0.5 https://vfhk.org/da/nyhed/forskningssamarbejde-har-banet-vejen-forbedret-indsats-mod-hudkraeft 2025-08-26T14:33:09+02:00 0.5 https://vfhk.org/en/news/new-research-can-cream-containing-madecassoside-and-5-panthenol-reduce-skin-reactions-after 2023-11-07T12:20:54+01:00 0.5 https://vfhk.org/da/nyhed/ny-forskning-kan-brug-af-creme-indeholdende-madecassoside-og-b5-vitamin-mindske-hudreaktioner 2023-11-07T12:20:54+01:00 0.5 https://vfhk.org/en/news/using-laser-technology-boost-immunotherapy-skin-cancer-rikke-christensen-defends-her-phd 2023-12-19T12:05:02+01:00 0.5 https://vfhk.org/da/nyhed/rikke-christensen-forsvarer-sin-phd-immunterapi-i-kombination-med-laser-kan-gavne 2023-12-19T12:05:02+01:00 0.5 https://vfhk.org/en/news/merry-christmas-and-thank-you-efforts-past-year 2023-12-21T09:32:59+01:00 0.5 https://vfhk.org/da/nyhed/glaedelig-jul-og-stor-tak-indsatsen-i-aaret-der-er-gaaet 2023-12-21T09:32:59+01:00 0.5 https://vfhk.org/en/news/unlocking-natures-shield-can-natural-dietary-supplements-defend-against-suns-harmful-uv-rays 2024-01-30T08:51:17+01:00 0.5 https://vfhk.org/da/nyhed/kan-vi-beskytte-os-mod-solens-farlige-straaler-ved-spise-et-kosttilskud 2024-01-30T08:51:17+01:00 0.5 https://vfhk.org/en/news/innovative-hpv-trial-enters-final-phase 2024-02-14T16:14:50+01:00 0.5 https://vfhk.org/da/nyhed/innovativt-hpv-forsoeg-gaar-ind-i-slutfasen 2024-02-14T16:14:50+01:00 0.5 https://vfhk.org/en/news/secrets-skin-does-exposed-body-surface-area-affect-amount-dna-damage-urine-after-uv-exposure 2024-03-21T09:47:12+01:00 0.5 https://vfhk.org/da/nyhed/hudens-hemmeligheder-har-eksponeret-kropsareal-betydning-maengden-af-dna-skade-i-urin-efter 2024-03-21T09:47:12+01:00 0.5 https://vfhk.org/en/news/exploring-accuracy-and-user-experience-chatgpt-actinic-keratosis 2024-04-02T13:08:45+02:00 0.5 https://vfhk.org/da/nyhed/chatgpt-og-aktinisk-keratose-en-undersoegelse-af-noejagtighed-og-brugeroplevelse 2024-04-02T13:08:45+02:00 0.5 https://vfhk.org/en/news/danish-research-center-skin-cancer-makes-splash-aslms-2024 2024-04-23T10:10:53+02:00 0.5 https://vfhk.org/da/nyhed/flot-prishoest-til-aslms-2024 2024-04-23T10:10:53+02:00 0.5 https://vfhk.org/en/news/patients-precursors-skin-cancer-can-benefit-new-effective-combination-therapy 2024-05-02T09:06:28+02:00 0.5 https://vfhk.org/da/nyhed/patienter-med-forstadier-til-hudkraeft-kan-nu-faa-gavn-af-ny-effektiv-kombinationsbehandling 2024-05-02T09:06:28+02:00 0.5 https://vfhk.org/en/news/its-never-too-late-begin-protecting-your-skin-uv-radiation 2024-05-07T12:38:14+02:00 0.5 https://vfhk.org/da/nyhed/det-er-aldrig-sent-gaa-i-gang-med-beskytte-sin-hud-mod-uv-straaling 2024-05-07T12:38:14+02:00 0.5 https://vfhk.org/en/news/public-private-research-collaboration-enhances-prevention-diagnosis-and-treatment-skin-cancer 2024-05-28T11:02:31+02:00 0.5 https://vfhk.org/da/nyhed/offentligt-privat-samarbejde-paa-hudkraeftomraadet-gavner-forebyggelse-diagnostik-og 2024-05-28T11:02:31+02:00 0.5 https://vfhk.org/en/news/lifetime-risk-skin-cancer-danes-approaches-22 2024-07-02T12:36:18+02:00 0.5 https://vfhk.org/da/nyhed/danskernes-livstidsrisiko-hudkraeft-naermer-sig-22 2024-07-02T12:36:18+02:00 0.5 https://vfhk.org/en/news/could-pill-be-sun-protective-supplement-future 2024-11-20T14:00:13+01:00 0.5 https://vfhk.org/da/nyhed/vil-en-pille-i-fremtiden-kunne-beskytte-os-mod-solens-skadelige-straaler 2024-11-20T14:00:13+01:00 0.5 https://vfhk.org/en/nyhed/tailored-screening-transplanted-women 2025-10-01T11:14:11+02:00 0.5 https://vfhk.org/da/nyhed/skraeddersyet-screening-til-transplanterede-kvinder 2025-10-01T11:14:11+02:00 0.5 https://vfhk.org/en/news/new-research-could-pave-way-improved-diagnostics-and-treatment-choices-actinic-keratoses 2024-11-20T13:32:44+01:00 0.5 https://vfhk.org/da/nyhed/ny-forskning-kan-bane-vejen-mere-praecis-diagnostik-og-behandlingsvalg-forstadier-til 2024-11-20T13:32:44+01:00 0.5 https://vfhk.org/en/news/what-phd-student-skin-cancer-doing-section-forensic-genetics 2024-11-20T13:24:52+01:00 0.5 https://vfhk.org/da/nyhed/hvad-laver-en-forsker-i-hudkraeft-paa-retsgenetisk-afdeling 2024-11-20T13:24:52+01:00 0.5 https://vfhk.org/da/nyhed/den-frie-forskningsfond-stoetter-unikt-projekt-om-hudaldring-og-hudkraeft 2024-11-20T13:26:22+01:00 0.5 https://vfhk.org/en/news/new-extensive-research-project-aims-protect-us-against-increasingly-extreme-heat 2024-11-27T11:59:46+01:00 0.5 https://vfhk.org/da/nyhed/nyt-stort-forskningsprojekt-skal-beskytte-os-mod-fremtidens-mere-og-mere-ekstreme-hede 2024-11-27T11:59:46+01:00 0.5 https://vfhk.org/en/nyhed/laser-treatment-removed-jakobs-precursors-skin-cancer-after-years-other-treatments 2025-09-24T15:21:40+02:00 0.5 https://vfhk.org/da/nyhed/laserbehandling-mod-forstadier-til-hudkraeft-er-nu-tilgaengelig-i-danmark-og-fik-bugt-med 2025-09-24T15:21:40+02:00 0.5 https://vfhk.org/en/nyhed/kick-collaboration-project-senescence-skin-and-skin-cancer 2025-03-06T14:28:23+01:00 0.5 https://vfhk.org/da/nyhed/kick-projektsamarbejde-om-hudaldring-og-hudkraeft 2025-03-06T14:28:23+01:00 0.5 https://vfhk.org/en/nyhed/groundbreaking-danish-research-shows-hpv-vaccination-can-reduce-precursors-skin-cancer 2025-03-11T11:13:49+01:00 0.5 https://vfhk.org/da/nyhed/banebrydende-dansk-forsoeg-viser-hpv-vaccine-kan-reducere-forstadier-til-hudkraeft 2025-03-11T11:13:49+01:00 0.5 https://vfhk.org/en/nyhed/danish-data-scientist-gains-new-perspectives-skin-cancer-through-stay-switzer-land 2025-04-29T13:54:32+02:00 0.5 https://vfhk.org/da/nyhed/ophold-i-schweiz-giver-dansk-talknuser-nye-perspektiver-paa-hudkraeft 2025-04-29T13:54:32+02:00 0.5 https://vfhk.org/en/nyhed/new-recommendation-you-should-always-use-sunscreen-least-spf-30 2025-03-19T10:01:41+01:00 0.5 https://vfhk.org/da/nyhed/ny-anbefaling-du-boer-altid-bruge-solcreme-med-mindst-faktor-30 2025-03-19T10:01:41+01:00 0.5 https://vfhk.org/en/nyhed/strong-collaboration-between-researchers-clinical-doctors-and-patients-trial-data-were 2025-04-22T10:22:11+02:00 0.5 https://vfhk.org/da/nyhed/med-staerkt-samarbejde-mellem-hudkraeftforskere-kliniklaeger-og-patienter-kom-forsoegsdata-i 2025-04-22T10:22:11+02:00 0.5 https://vfhk.org/en/nyhed/two-very-special-weeks-danish-research-center-skin-cancer 2025-04-22T10:14:06+02:00 0.5 https://vfhk.org/da/nyhed/saerlige-uger-i-videncenter-hudkraeft 2025-04-22T10:14:06+02:00 0.5 https://vfhk.org/en/nyhed/prevention-skin-cancer-was-agenda-usas-largest-conference-laser-medical-treatment 2025-05-15T12:38:37+02:00 0.5 https://vfhk.org/da/nyhed/forebyggelse-af-hudkraeft-var-paa-dagsordenen-paa-usas-stoerst-konference-om-laser-til 2025-05-15T12:38:37+02:00 0.5 https://vfhk.org/en/nyhed/when-kidney-transplanted-claus-also-developed-skin-cancer-chief-physician-dermatology 2025-08-27T16:31:23+02:00 0.5 https://vfhk.org/da/nyhed/da-nyretransplanterede-claus-ogsaa-fik-hudkraeft-gav-en-overlaege-paa-hudafdelingen-ham-indre 2025-08-27T16:31:23+02:00 0.5 https://vfhk.org/en/nyhed/morning-lars-lolland 2025-05-28T12:17:52+02:00 0.5 https://vfhk.org/da/nyhed/en-formiddag-som-lars-fra-lolland 2025-05-28T12:17:52+02:00 0.5 https://vfhk.org/en/nyhed/strong-representation-photobiology-congress-italy-and-recognition-one-our-young-researchers 2025-09-10T11:41:48+02:00 0.5 https://vfhk.org/da/nyhed/staerk-repraesentation-paa-kongres-photobiologi-i-italien-og-haeder-til-en-af-vores-unge 2025-09-10T11:41:48+02:00 0.5 https://vfhk.org/en/nyhed/close-study-data-income-and-distance-dermatologist-provides-new-insight-skin-cancer 2025-10-01T12:45:16+02:00 0.5 https://vfhk.org/da/nyhed/granskning-af-data-om-indkomst-og-afstand-til-hudlaege-giver-ny-indsigt-i-hudkraeft 2025-10-01T12:45:16+02:00 0.5 https://vfhk.org/en/nyhed/another-recognition-one-our-young-researchers 2025-09-24T09:56:29+02:00 0.5 https://vfhk.org/da/nyhed/endnu-en-anerkendelse-til-en-af-vores-unge-forskere-i-hudkraeft 2025-09-24T09:56:29+02:00 0.5 https://vfhk.org/en/nyhed/get-medical-explanations-everyday-language-just-few-clicks 2025-09-23T11:16:09+02:00 0.5 https://vfhk.org/da/nyhed/faa-de-laegefaglige-forklaringer-paa-hudkraeft-i-hverdagssprog-med-et-par-klik 2025-09-23T11:16:09+02:00 0.5 https://vfhk.org/en/nyhed/project-vitamin-b3-and-fern-extract-sun-protection-enters-final-phase 2025-10-07T12:13:46+02:00 0.5 https://vfhk.org/da/nyhed/projekt-om-b3-vitamin-og-bregneekstrakt-til-solbeskyttelse-gaar-ind-i-sidste-fase 2025-10-07T12:13:46+02:00 0.5 https://vfhk.org/en/nyhed/ottos-journey-skin-cancer-research 2026-02-03T14:56:52+01:00 0.5 https://vfhk.org/da/nyhed/ottos-rejse-ind-i-hudkraeftforskningen 2026-02-03T14:56:52+01:00 0.5 https://vfhk.org/en/nyhed/kevin-jacobsen-won-imca-award-paris 2026-02-11T09:27:33+01:00 0.5 https://vfhk.org/da/nyhed/kevin-jacobsen-loeb-med-prisen-i-paris 2026-02-11T09:27:33+01:00 0.5 https://vfhk.org/en/nyhed/little-uv-meter-updated-wiser-version 2026-05-05T15:26:56+02:00 0.5 https://vfhk.org/da/nyhed/lille-uv-maaler-bliver-endnu-klogere 2026-05-05T15:26:56+02:00 0.5 https://vfhk.org/en/nyhed/patients-high-risk-developing-melanoma-may-need-psychological-support 2026-05-05T15:48:39+02:00 0.5 https://vfhk.org/da/nyhed/patienter-med-hoej-risiko-modermaerkekraeft-kan-have-behov-psykologisk-stoette 2026-05-05T15:48:39+02:00 0.5 https://vfhk.org/en/nyhed/research-project-could-pill-provide-same-protection-sunscreen 2026-06-30T15:12:30+02:00 0.5 https://vfhk.org/da/nyhed/forskningsprojekt-vil-en-pille-kunne-give-lige-saa-god-effekt-som-med-solcreme 2026-06-30T15:12:30+02:00 0.5 https://vfhk.org/en/nyhed/new-phd-how-large-societal-burden-most-common-type-skin-cancer 2026-06-23T14:47:19+02:00 0.5 https://vfhk.org/da/nyhed/ny-phd-hvor-stor-er-den-samfundsmaessige-byrde-den-mest-almindelige-type-af-hudkraeft 2026-06-23T14:47:19+02:00 0.5 https://vfhk.org/en/nyhed/new-project-nurse 2026-06-30T12:16:06+02:00 0.5 https://vfhk.org/da/nyhed/ny-projektsygeplejerske-paa-centeret-skal-arbejde-med-patienter-og-forskningsprojekter-i 2026-06-30T12:16:06+02:00 0.5 https://vfhk.org/en/nyhed/sara-taking-break-her-medical-studies-do-research-skin-cancer 2026-06-30T15:04:28+02:00 0.5 https://vfhk.org/da/nyhed/sara-tager-en-pause-fra-medicinstudiet-forske-i-hudkraeft-og-non-invasive-behandlingsmetoder 2026-06-30T15:04:28+02:00 0.5 https://vfhk.org/en/nyhed/we-need-talk-more-about-bad-data 2026-08-05T11:52:00+02:00 0.5 https://vfhk.org/da/nyhed/forskning-skal-laves-paa-kvalitetsdata-men-vi-er-noedt-til-tale-mere-om-daarlig-data 2026-08-05T11:52:00+02:00 0.5 https://vfhk.org/da/nyhed/ny-bevilling-til-forskning-kan-laser-forebygge-hudkraeft 2026-09-01T09:50:27+02:00 0.5 https://vfhk.org/en/article/partners-and-collaborators 2023-07-05T10:58:42+02:00 0.5 https://vfhk.org/da/simpel-side/partnere-og-samarbejdspartnere 2023-07-05T10:58:42+02:00 0.5 https://vfhk.org/en/article/vision-and-purpose 2025-01-28T16:29:55+01:00 0.5 https://vfhk.org/da/simpel-side/vision-og-formaal 2025-01-28T16:29:55+01:00 0.5 https://vfhk.org/en/article/guidelines-prevention-and-treatment-skin-cancer 2025-09-18T12:23:55+02:00 0.5 https://vfhk.org/da/simpel-side/guidelines-behandling-og-forebyggelse-af-hudkraeft 2025-09-18T12:23:55+02:00 0.5 https://vfhk.org/en/article/privacy-policy 2025-04-30T16:28:24+02:00 0.5 https://vfhk.org/da/simpel-side/privatlivspolitik 2025-04-30T16:28:24+02:00 0.5 https://vfhk.org/en/article/vacancies 2024-03-12T10:39:04+01:00 0.5 https://vfhk.org/da/simpel-side/ledige-stillinger 2024-03-12T10:39:04+01:00 0.5 https://vfhk.org/en/article/organization 2024-02-06T09:40:07+01:00 0.5 https://vfhk.org/da/simpel-side/organisation 2024-02-06T09:40:07+01:00 0.5 https://vfhk.org/en/article/what-skin-cancer 2025-10-16T10:19:29+02:00 0.5 https://vfhk.org/da/simpel-side/hvad-er-hudkraeft 2025-10-16T10:19:29+02:00 0.5 https://vfhk.org/en/article/risk-skin-cancer-patients 2025-10-16T10:51:08+02:00 0.5 https://vfhk.org/da/simpel-side/hudkraeft-og-saerligt-udsatte-patienter 2025-10-16T10:51:08+02:00 0.5 https://vfhk.org/en/article/skin-cancer-epidemiology 2025-10-14T11:40:51+02:00 0.5 https://vfhk.org/da/simpel-side/hvor-hyppig-er-hudkraeft 2025-10-14T11:40:51+02:00 0.5 https://vfhk.org/en/article/press 2026-01-28T12:12:45+01:00 0.5 https://vfhk.org/da/simpel-side/presse 2026-01-28T12:12:45+01:00 0.5 https://vfhk.org/en/article/join-clinical-study 2026-03-24T10:24:20+01:00 0.5 https://vfhk.org/da/simpel-side/deltag-i-kliniske-forsoeg 2026-03-24T10:24:20+01:00 0.5 https://vfhk.org/en/article/withdrawal-consent 2022-02-01T11:00:29+01:00 0.5 https://vfhk.org/da/simpel-side/tilbagetraekning-af-samtykke 2022-02-01T11:00:29+01:00 0.5 https://vfhk.org/en/article/annual-report 2025-06-10T12:32:35+02:00 0.5 https://vfhk.org/da/simpel-side/aarsrapport 2025-06-10T12:32:35+02:00 0.5 https://vfhk.org/en/article/reduce-risk-developing-skin-cancer 2025-10-16T10:58:26+02:00 0.5 https://vfhk.org/da/simpel-side/saadan-forebygger-du-hudkraeft 2025-10-16T10:58:26+02:00 0.5 https://vfhk.org/en/article/skin-cancer-treatment 2025-10-28T15:11:45+01:00 0.5 https://vfhk.org/da/simpel-side/behandling-af-hudkraeft 2025-10-28T15:11:45+01:00 0.5 https://vfhk.org/en/article/skin-cancer-examination-and-diagnostics 2025-10-16T10:54:46+02:00 0.5 https://vfhk.org/da/simpel-side/undersoegelse-og-diagnose-af-hudkraeft 2025-10-16T10:54:46+02:00 0.5 https://vfhk.org/da/simpel-side/403 2022-03-08T13:33:28+01:00 0.5 https://vfhk.org/da/simpel-side/404 2022-03-08T13:36:30+01:00 0.5 https://vfhk.org/en/article/follow-us-social-media 2026-08-19T14:09:46+02:00 0.5 https://vfhk.org/da/simpel-side/foelg-med-paa-sociale-medier 2026-08-19T14:09:46+02:00 0.5 https://vfhk.org/da/simpel-side/forsoegspersoner-soeges-til-projektet-bestemmelse-af-dna-reparation-i-urin 2024-06-11T08:12:48+02:00 0.5 https://vfhk.org/en/article/using-vfhkorg-and-subpages 2025-01-28T16:21:40+01:00 0.5 https://vfhk.org/da/simpel-side/om-brug-af-hjemmesiden 2025-01-28T16:21:40+01:00 0.5 https://vfhk.org/en/article/contact 2026-08-19T13:43:43+02:00 0.5 https://vfhk.org/da/simpel-side/kontakt-0 2026-08-19T13:43:43+02:00 0.5 https://vfhk.org/en/article/search-engine-targeting-skin-cancer 2025-10-16T12:11:54+02:00 0.5 https://vfhk.org/da/simpel-side/soegemaskine-til-hudkraeft 2025-10-16T12:11:54+02:00 0.5 https://vfhk.org/en/partner/danish-cancer-society 2022-02-08T11:57:16+01:00 0.5 https://vfhk.org/da/partner/kraeftens-bekaempelse 2022-02-08T11:57:16+01:00 0.5 https://vfhk.org/da/partner/computerome 2022-02-19T16:51:42+01:00 0.5 https://vfhk.org/da/partner/greater-copenhagen 2022-03-01T11:05:38+01:00 0.5 https://vfhk.org/da/partner/r-rox-anderson 2022-02-19T15:18:54+01:00 0.5 https://vfhk.org/da/partner/shawn-demehri 2022-02-20T16:45:29+01:00 0.5 https://vfhk.org/en/partner/aalborg-university 2022-02-01T13:37:00+01:00 0.5 https://vfhk.org/da/partner/aalborg-universitet 2022-02-01T13:37:00+01:00 0.5 https://vfhk.org/da/partner/dtu-danmarks-tekniske-universitet 2022-02-19T16:53:55+01:00 0.5 https://vfhk.org/da/partner/marc-clement 2022-10-06T16:22:39+02:00 0.5 https://vfhk.org/da/partner/uwe-paasch 2022-09-12T15:50:57+02:00 0.5 https://vfhk.org/en/project/topical-immune-activator-potential-modality-skin-cancer-treatment 2025-01-28T11:49:44+01:00 0.5 https://vfhk.org/da/projekt/topikal-immunaktivator-en-mulig-behandlingsmulighed-til-hudkraeft 2025-01-28T11:49:44+01:00 0.5 https://vfhk.org/en/project/combination-laser-and-topical-hedgehog-inhibitor-treat-basal-cell-carcinoma-pre-clinical 2025-01-28T11:39:11+01:00 0.5 https://vfhk.org/da/projekt/brug-af-en-kombination-af-laser-og-topikal-hedgehog-inhibitor-behandle-basalcelle 2025-01-28T11:39:11+01:00 0.5 https://vfhk.org/en/projekt/tumor-biomarkers-mass-spectrometry-imaging-discovering-skin-cancer-signature 2026-08-19T13:19:33+02:00 0.5 https://vfhk.org/da/projekt/tumor-biomarkoerer-i-hudkraeft-ved-hjaelp-af-billeddannende-massespektrometri 2026-08-19T13:19:33+02:00 0.5 https://vfhk.org/en/project/local-targeted-immunotherapy-treatment-squamous-cell-carcinomas 2023-12-14T08:14:52+01:00 0.5 https://vfhk.org/da/projekt/lokal-maalrettet-immunterapi-til-behandling-af-planocellulaer-hudkraeft 2023-12-14T08:14:52+01:00 0.5 https://vfhk.org/en/projekt/pharmacological-photoprotection-pre-clinical-skin-cancer-model 2026-08-19T13:22:31+02:00 0.5 https://vfhk.org/da/projekt/farmakologisk-fotobeskyttelse-i-en-praeklinisk-hudkraeft-model 2026-08-19T13:22:31+02:00 0.5 https://vfhk.org/en/project/pretreatment-topical-5-fluorouracil-daylight-photodynamic-therapy-actinic-keratoses 2025-08-26T16:28:55+02:00 0.5 https://vfhk.org/da/projekt/forbehandling-med-topikal-5-fluorouracil-foer-dagslys-fotodynamisk-terapi-af-aktiniske 2025-08-26T16:28:55+02:00 0.5 https://vfhk.org/en/project/calcium-electroporation-treatment-basal-cell-carcinoma-proof-concept-study 2023-08-17T13:38:19+02:00 0.5 https://vfhk.org/da/projekt/calcium-elektroporation-til-behandling-af-basalcellekarcinomer-et-proof-concept-studium 2023-08-17T13:38:19+02:00 0.5 https://vfhk.org/en/project/topical-delivery-topical-vismodegib-basal-cell-carcinomas 2023-08-17T13:18:13+02:00 0.5 https://vfhk.org/da/projekt/topikal-levering-af-vismodegib-i-basalcelle-hudkraeft 2023-08-17T13:18:13+02:00 0.5 https://vfhk.org/en/project/decentralized-clinical-trial-treatment-skin-cancer-precursor-lesions 2023-08-17T13:47:54+02:00 0.5 https://vfhk.org/da/projekt/decentraliseret-klinisk-forsoeg-til-behandling-af-forstadier-af-hudkraeft 2023-08-17T13:47:54+02:00 0.5 https://vfhk.org/en/project/laser-immunotherapy-and-without-topical-anti-pd1-basal-cell-carcinomas-bcc 2023-08-17T13:40:56+02:00 0.5 https://vfhk.org/da/projekt/laser-immunterapi-med-og-uden-lokal-anti-pd1-til-behandling-af-basalcelle-karcinomer 2023-08-17T13:40:56+02:00 0.5 https://vfhk.org/en/project/mass-spectrometry-based-analytical-methods-quantification-and-identification-biological 2023-08-17T13:20:43+02:00 0.5 https://vfhk.org/da/projekt/massespektrometri-baserede-analysemetoder-til-kvantificering-og-identificering-af 2023-08-17T13:20:43+02:00 0.5 https://vfhk.org/en/projekt/systemic-photoprotection-organ-transplant-recipients 2026-08-19T13:15:19+02:00 0.5 https://vfhk.org/da/projekt/systemisk-fotobeskyttelse-af-organtransplanterede 2026-08-19T13:15:19+02:00 0.5 https://vfhk.org/en/projekt/epidemiological-studies-non-melanoma-skin-cancer 2026-08-19T13:17:58+02:00 0.5 https://vfhk.org/da/projekt/epidemiologiske-studier-af-non-melanoma-hudkraeft 2026-08-19T13:17:58+02:00 0.5 https://vfhk.org/en/project/determination-dna-repair-products-urine-after-uv-irradiation-skin 2023-12-14T10:27:55+01:00 0.5 https://vfhk.org/da/projekt/bestemmelse-af-dna-repair-produkter-i-urin-efter-uv-bestraaling-af-huden 2023-12-14T10:27:55+01:00 0.5 https://vfhk.org/en/project/line-field-confocal-optical-coherence-tomography-dermato-oncology-opportunities-and 2026-06-30T15:22:39+02:00 0.5 https://vfhk.org/da/projekt/line-field-confocal-optical-coherence-tomography-i-dermato-onkologi-muligheder-og 2026-06-30T15:22:39+02:00 0.5 https://vfhk.org/en/project/impact-cream-containing-madecassocide-and-5-panthenol-post-photodynamic-therapy-procedure 2026-06-30T15:22:16+02:00 0.5 https://vfhk.org/da/projekt/betydning-af-creme-indeholdende-madecassocide-og-5-panthenol-som-post-fotodynamisk 2026-06-30T15:22:16+02:00 0.5 https://vfhk.org/en/project/evaluation-immunotherapeutic-approaches-keratinocyte-carcinoma-treatment-preclinical-models 2026-06-30T15:20:55+02:00 0.5 https://vfhk.org/da/projekt/evaluering-af-immunterapi-baserede-tilgange-til-behandling-af-keratinocyt-karcinom-i 2026-06-30T15:20:55+02:00 0.5 https://vfhk.org/en/projekt/hpv-and-skin-cancer-organ-transplant-patients 2025-12-29T14:55:11+01:00 0.5 https://vfhk.org/da/projekt/hpv-og-hudkraeft-hos-organtransplanterede-patienter 2025-12-29T14:55:11+01:00 0.5 https://vfhk.org/en/publication/bleomycin-administered-laser-assisted-drug-delivery-or-intradermal-needle-injection 2021-07-05T12:27:07+02:00 0.5 https://vfhk.org/da/publikation/bleomycin-administered-laser-assisted-drug-delivery-or-intradermal-needle-injection 2021-07-05T12:27:07+02:00 0.5 https://vfhk.org/en/publication/thermo-mechanical-fractional-injury-enhances-skin-surface-and-epidermis-protoporphyrin 2021-07-06T09:07:02+02:00 0.5 https://vfhk.org/da/publikation/thermo-mechanical-fractional-injury-enhances-skin-surface-and-epidermis-protoporphyrin 2021-07-06T09:07:02+02:00 0.5 https://vfhk.org/en/publication/skin-cancer-prophylaxis-study-hairless-mice-using-methylene-blue-riboflavin-and-methyl 2021-07-06T11:33:35+02:00 0.5 https://vfhk.org/da/publikation/skin-cancer-prophylaxis-study-hairless-mice-using-methylene-blue-riboflavin-and-methyl 2021-07-06T11:33:35+02:00 0.5 https://vfhk.org/en/publication/how-much-protoporphyrin-ix-must-be-activated-obtain-full-efficacy-methyl 2021-07-06T11:31:56+02:00 0.5 https://vfhk.org/da/publikation/how-much-protoporphyrin-ix-must-be-activated-obtain-full-efficacy-methyl 2021-07-06T11:31:56+02:00 0.5 https://vfhk.org/en/publication/tumor-clearance-and-immune-cell-recruitment-uv-induced-murine-squamous-cell-carcinoma 2022-09-08T12:03:07+02:00 0.5 https://vfhk.org/da/publikation/tumor-clearance-and-immune-cell-recruitment-uv-induced-murine-squamous-cell-carcinoma 2022-09-08T12:03:07+02:00 0.5 https://vfhk.org/en/publication/exploring-utility-deep-red-anthraquinone-5-digital-staining-ex-vivo-confocal 2021-07-06T11:37:07+02:00 0.5 https://vfhk.org/da/publikation/exploring-utility-deep-red-anthraquinone-5-digital-staining-ex-vivo-confocal 2021-07-06T11:37:07+02:00 0.5 https://vfhk.org/en/publication/comparison-human-and-porcine-skin-laser-assisted-drug-delivery-chemotherapeutics 2021-07-06T11:39:40+02:00 0.5 https://vfhk.org/da/publikation/comparison-human-and-porcine-skin-laser-assisted-drug-delivery-chemotherapeutics 2021-07-06T11:39:40+02:00 0.5 https://vfhk.org/en/publication/assessment-laser-induced-thermal-damage-fresh-skin-ex-vivo-confocal-microscopy 2021-12-21T16:11:52+01:00 0.5 https://vfhk.org/da/publikation/assessment-laser-induced-thermal-damage-fresh-skin-ex-vivo-confocal-microscopy 2021-12-21T16:11:52+01:00 0.5 https://vfhk.org/en/publication/topical-delivery-nivolumab-therapeutic-antibody-fractional-laser-and-pneumatic 2021-07-06T11:45:09+02:00 0.5 https://vfhk.org/da/publikation/topical-delivery-nivolumab-therapeutic-antibody-fractional-laser-and-pneumatic 2021-07-06T11:45:09+02:00 0.5 https://vfhk.org/en/publication/electronic-pneumatic-injection-assisted-dermal-drug-delivery-visualized-ex-vivo 2021-07-06T11:50:35+02:00 0.5 https://vfhk.org/da/publikation/electronic-pneumatic-injection-assisted-dermal-drug-delivery-visualized-ex-vivo 2021-07-06T11:50:35+02:00 0.5 https://vfhk.org/en/publication/efficacy-and-safety-laser-assisted-combination-chemotherapy-explorative-imaging-guided 2023-01-17T14:25:47+01:00 0.5 https://vfhk.org/da/publikation/efficacy-and-safety-laser-assisted-combination-chemotherapy-explorative-imaging-guided 2023-01-17T14:25:47+01:00 0.5 https://vfhk.org/en/publication/sustained-improvement-surgical-scar-appearance-1-year-after-early-intervention 2021-07-06T11:55:45+02:00 0.5 https://vfhk.org/da/publikation/sustained-improvement-surgical-scar-appearance-1-year-after-early-intervention 2021-07-06T11:55:45+02:00 0.5 https://vfhk.org/en/publication/enhanced-and-sustained-cutaneous-delivery-vismodegib-ablative-fractional-laser-and 2021-07-06T11:58:04+02:00 0.5 https://vfhk.org/da/publikation/enhanced-and-sustained-cutaneous-delivery-vismodegib-ablative-fractional-laser-and 2021-07-06T11:58:04+02:00 0.5 https://vfhk.org/en/publication/efficacy-and-tolerability-intralesional-bleomycin-dermatology-systematic-review 2021-07-06T12:27:18+02:00 0.5 https://vfhk.org/da/publikation/efficacy-and-tolerability-intralesional-bleomycin-dermatology-systematic-review 2021-07-06T12:27:18+02:00 0.5 https://vfhk.org/en/publication/reduction-actinic-keratoses-following-9-valent-human-papilloma-virus-vaccination 2021-07-06T12:29:16+02:00 0.5 https://vfhk.org/da/publikation/reduction-actinic-keratoses-following-9-valent-human-papilloma-virus-vaccination 2021-07-06T12:29:16+02:00 0.5 https://vfhk.org/en/publication/melanin-has-small-inhibitory-effect-cutaneous-vitamin-d-synthesis-comparison-extreme 2021-07-06T12:31:27+02:00 0.5 https://vfhk.org/da/publikation/melanin-has-small-inhibitory-effect-cutaneous-vitamin-d-synthesis-comparison-extreme 2021-07-06T12:31:27+02:00 0.5 https://vfhk.org/en/publication/skin-surface-protoporphyrin-ix-fluorescence-associated-epidermal-not-dermal 2021-07-06T12:35:49+02:00 0.5 https://vfhk.org/da/publikation/skin-surface-protoporphyrin-ix-fluorescence-associated-epidermal-not-dermal 2021-07-06T12:35:49+02:00 0.5 https://vfhk.org/en/publication/human-papillomavirus-related-anogenital-premalignancies-and-cancer-renal-transplant 2021-07-06T12:37:47+02:00 0.5 https://vfhk.org/da/publikation/human-papillomavirus-related-anogenital-premalignancies-and-cancer-renal-transplant 2021-07-06T12:37:47+02:00 0.5 https://vfhk.org/en/publication/basal-cell-carcinoma-treated-combined-ablative-fractional-laser-and-ingenol-mebutate 2021-07-06T12:40:15+02:00 0.5 https://vfhk.org/da/publikation/basal-cell-carcinoma-treated-combined-ablative-fractional-laser-and-ingenol-mebutate 2021-07-06T12:40:15+02:00 0.5 https://vfhk.org/en/publication/prevalence-type-distribution-and-risk-factors-oral-hpv-danish-renal-transplant 2021-07-06T12:42:25+02:00 0.5 https://vfhk.org/da/publikation/prevalence-type-distribution-and-risk-factors-oral-hpv-danish-renal-transplant 2021-07-06T12:42:25+02:00 0.5 https://vfhk.org/en/publication/ablative-fractional-laser-assisted-treatments-keratinocyte-carcinomas-and-its 2021-07-06T12:46:11+02:00 0.5 https://vfhk.org/da/publikation/ablative-fractional-laser-assisted-treatments-keratinocyte-carcinomas-and-its 2021-07-06T12:46:11+02:00 0.5 https://vfhk.org/en/publication/fundamentals-fractional-laser-assisted-drug-delivery-depth-guide-experimental 2023-04-11T11:46:27+02:00 0.5 https://vfhk.org/da/publikation/fundamentals-fractional-laser-assisted-drug-delivery-depth-guide-experimental 2023-04-11T11:46:27+02:00 0.5 https://vfhk.org/en/publication/needle-free-injection-assisted-drug-delivery-histological-characterization-cutaneous 2021-07-06T12:50:30+02:00 0.5 https://vfhk.org/da/publikation/needle-free-injection-assisted-drug-delivery-histological-characterization-cutaneous 2021-07-06T12:50:30+02:00 0.5 https://vfhk.org/en/publication/fractional-1927-nm-thulium-laser-plus-photodynamic-therapy-compared-and-combined 2021-07-06T12:52:33+02:00 0.5 https://vfhk.org/da/publikation/fractional-1927-nm-thulium-laser-plus-photodynamic-therapy-compared-and-combined 2021-07-06T12:52:33+02:00 0.5 https://vfhk.org/en/publication/lifetime-uvr-dose-and-skin-cancer-risk-determined-their-common-relation-solar 2021-07-06T12:55:54+02:00 0.5 https://vfhk.org/da/publikation/lifetime-uvr-dose-and-skin-cancer-risk-determined-their-common-relation-solar 2021-07-06T12:55:54+02:00 0.5 https://vfhk.org/en/publication/improving-photoprotection-and-implications-25ohd-formation 2021-07-06T13:01:46+02:00 0.5 https://vfhk.org/da/publikation/improving-photoprotection-and-implications-25ohd-formation 2021-07-06T13:01:46+02:00 0.5 https://vfhk.org/en/publication/handful-sunscreen-whole-body-application 2021-07-06T13:03:30+02:00 0.5 https://vfhk.org/da/publikation/handful-sunscreen-whole-body-application 2021-07-06T13:03:30+02:00 0.5 https://vfhk.org/en/publication/risk-anal-high-grade-squamous-intraepithelial-lesions-among-renal-transplant-recipients 2023-02-02T12:26:50+01:00 0.5 https://vfhk.org/da/publikation/risk-anal-high-grade-squamous-intraepithelial-lesions-among-renal-transplant-recipients 2023-02-02T12:26:50+01:00 0.5 https://vfhk.org/en/publication/exploring-bleomycin-derma-oncology-energy-based-topical-drug-delivery 2024-06-13T08:47:14+02:00 0.5 https://vfhk.org/da/publikation/exploring-bleomycin-derma-oncology-energy-based-topical-drug-delivery 2024-06-13T08:47:14+02:00 0.5 https://vfhk.org/en/publication/keratinocyte-dysplasia-organ-transplant-recipients-treatment-and-prevention 2022-03-11T12:53:43+01:00 0.5 https://vfhk.org/da/publikation/keratinocyte-dysplasia-organ-transplant-recipients-treatment-and-prevention 2022-03-11T12:53:43+01:00 0.5 https://vfhk.org/en/publication/keratinocyte-carcinoma-and-photoprevention-protective-actions-repurposed 2023-02-21T14:32:26+01:00 0.5 https://vfhk.org/da/publikation/keratinocyte-carcinoma-and-photoprevention-protective-actions-repurposed 2023-02-21T14:32:26+01:00 0.5 https://vfhk.org/en/publication/electrochemotherapy-bleomycin-basal-cell-carcinomas-systematic-review 2022-09-08T12:38:44+02:00 0.5 https://vfhk.org/da/publikation/electrochemotherapy-bleomycin-basal-cell-carcinomas-systematic-review 2022-09-08T12:38:44+02:00 0.5 https://vfhk.org/en/publication/anti-pd-1-therapy-adjuvant-ablative-fractional-laser-improves-anti-tumor-response-basal 2023-02-21T14:34:42+01:00 0.5 https://vfhk.org/da/publikation/anti-pd-1-therapy-adjuvant-ablative-fractional-laser-improves-anti-tumor-response-basal 2023-02-21T14:34:42+01:00 0.5 https://vfhk.org/en/publication/low-vitamin-d-dark-skinned-immigrants-mainly-due-clothing-habits-and-low-uvr-exposure 2022-09-08T12:53:19+02:00 0.5 https://vfhk.org/da/publikation/low-vitamin-d-dark-skinned-immigrants-mainly-due-clothing-habits-and-low-uvr-exposure 2022-09-08T12:53:19+02:00 0.5 https://vfhk.org/en/publication/revised-action-spectrum-vitamin-d-synthesis-suberythemal-uv-radiation-exposure-humans 2022-09-08T12:58:33+02:00 0.5 https://vfhk.org/da/publikation/revised-action-spectrum-vitamin-d-synthesis-suberythemal-uv-radiation-exposure-humans 2022-09-08T12:58:33+02:00 0.5 https://vfhk.org/en/publication/few-x-ray-and-puva-treatments-accelerate-photocarcinogenesis-hairless-mice 2022-09-08T13:02:39+02:00 0.5 https://vfhk.org/da/publikation/few-x-ray-and-puva-treatments-accelerate-photocarcinogenesis-hairless-mice 2022-09-08T13:02:39+02:00 0.5 https://vfhk.org/en/publication/laser-immunotherapy-potential-treatment-modality-keratinocyte-carcinoma 2023-02-02T12:28:24+01:00 0.5 https://vfhk.org/da/publikation/laser-immunotherapy-potential-treatment-modality-keratinocyte-carcinoma 2023-02-02T12:28:24+01:00 0.5 https://vfhk.org/en/publication/12-month-follow-split-scalp-study-comparing-calcipotriol-assisted-mal-pdt-conventional 2022-09-08T13:15:15+02:00 0.5 https://vfhk.org/da/publikation/12-month-follow-split-scalp-study-comparing-calcipotriol-assisted-mal-pdt-conventional 2022-09-08T13:15:15+02:00 0.5 https://vfhk.org/en/publication/label-9-valent-human-papillomavirus-vaccination-actinic-keratosis-case-series 2023-04-11T11:47:11+02:00 0.5 https://vfhk.org/da/publikation/label-9-valent-human-papillomavirus-vaccination-actinic-keratosis-case-series 2023-04-11T11:47:11+02:00 0.5 https://vfhk.org/en/publication/risk-anogenital-warts-renal-transplant-recipients-compared-immunocompetent-controls 2023-01-17T14:20:34+01:00 0.5 https://vfhk.org/da/publikation/risk-anogenital-warts-renal-transplant-recipients-compared-immunocompetent-controls 2023-01-17T14:20:34+01:00 0.5 https://vfhk.org/en/publication/delineating-papillary-dermis-around-basal-cell-carcinomas-high-and-ultrahigh-resolution 2022-09-08T13:27:59+02:00 0.5 https://vfhk.org/da/publikation/delineating-papillary-dermis-around-basal-cell-carcinomas-high-and-ultrahigh-resolution 2022-09-08T13:27:59+02:00 0.5 https://vfhk.org/en/publication/assessing-light-and-energy-based-therapy-optical-coherence-tomography-and-reflectance 2022-09-08T13:34:29+02:00 0.5 https://vfhk.org/da/publikation/assessing-light-and-energy-based-therapy-optical-coherence-tomography-and-reflectance 2022-09-08T13:34:29+02:00 0.5 https://vfhk.org/en/publication/topical-delivery-pd-1-inhibitors-laser-assisted-passive-diffusion-and-active 2022-09-08T13:57:07+02:00 0.5 https://vfhk.org/da/publikation/topical-delivery-pd-1-inhibitors-laser-assisted-passive-diffusion-and-active 2022-09-08T13:57:07+02:00 0.5 https://vfhk.org/en/publication/efficacy-and-safety-laser-assisted-combination-chemotherapy-follow-study-treatment-5 2022-09-08T14:08:35+02:00 0.5 https://vfhk.org/da/publikation/efficacy-and-safety-laser-assisted-combination-chemotherapy-follow-study-treatment-5 2022-09-08T14:08:35+02:00 0.5 https://vfhk.org/en/publication/differentiation-between-benign-and-malignant-pigmented-skin-tumours-using-bedside 2022-12-20T16:08:49+01:00 0.5 https://vfhk.org/da/publikation/differentiation-between-benign-and-malignant-pigmented-skin-tumours-using-bedside 2022-12-20T16:08:49+01:00 0.5 https://vfhk.org/en/publication/vivo-dermal-delivery-bleomycin-electronic-pneumatic-injection-drug-visualization-and 2022-09-08T14:18:50+02:00 0.5 https://vfhk.org/da/publikation/vivo-dermal-delivery-bleomycin-electronic-pneumatic-injection-drug-visualization-and 2022-09-08T14:18:50+02:00 0.5 https://vfhk.org/en/publication/visualization-energy-based-device-induced-thermal-tissue-alterations-using-bimodal-ex 2022-09-08T14:29:38+02:00 0.5 https://vfhk.org/da/publikation/visualization-energy-based-device-induced-thermal-tissue-alterations-using-bimodal-ex 2022-09-08T14:29:38+02:00 0.5 https://vfhk.org/en/publication/anal-human-papillomavirus-infection-kidney-transplant-recipients-compared 2022-12-15T09:09:39+01:00 0.5 https://vfhk.org/da/publikation/anal-human-papillomavirus-infection-kidney-transplant-recipients-compared 2022-12-15T09:09:39+01:00 0.5 https://vfhk.org/en/publication/local-vasoregulative-interventions-impact-drug-concentrations-skin-after-topical-laser 2023-04-11T11:47:53+02:00 0.5 https://vfhk.org/da/publikation/local-vasoregulative-interventions-impact-drug-concentrations-skin-after-topical-laser 2023-04-11T11:47:53+02:00 0.5 https://vfhk.org/en/publication/2021-international-consensus-statement-optical-coherence-tomography-basal-cell 2022-09-08T14:58:37+02:00 0.5 https://vfhk.org/da/publikation/2021-international-consensus-statement-optical-coherence-tomography-basal-cell 2022-09-08T14:58:37+02:00 0.5 https://vfhk.org/en/publication/optical-imaging-visualizes-homogeneous-and-horizontal-band-biodistribution-large-and 2022-12-15T08:54:39+01:00 0.5 https://vfhk.org/da/publikation/optical-imaging-visualizes-homogeneous-and-horizontal-band-biodistribution-large-and 2022-12-15T08:54:39+01:00 0.5 https://vfhk.org/en/publication/cyclic-photodynamic-therapy-delays-first-onset-actinic-keratoses-renal-transplant 2022-12-20T16:13:49+01:00 0.5 https://vfhk.org/da/publikation/cyclic-photodynamic-therapy-delays-first-onset-actinic-keratoses-renal-transplant 2022-12-20T16:13:49+01:00 0.5 https://vfhk.org/en/publication/non-melanoma-skin-cancer-organ-transplant-recipients-screening-prevention-treatment-and 2023-02-21T15:17:32+01:00 0.5 https://vfhk.org/da/publikation/non-melanom-hudcancer-hos-organtransplanterede-screening-forebyggelse-behandling-og 2023-02-21T15:17:32+01:00 0.5 https://vfhk.org/en/publication/needle-free-jet-injection-induced-small-droplet-aerosol-formation-during-intralesional 2023-02-21T15:16:17+01:00 0.5 https://vfhk.org/da/publikation/needle-free-jet-injection-induced-small-droplet-aerosol-formation-during-intralesional 2023-02-21T15:16:17+01:00 0.5 https://vfhk.org/en/publication/development-core-outcome-set-basal-cell-carcinoma 2022-12-15T09:23:18+01:00 0.5 https://vfhk.org/da/publikation/development-core-outcome-set-basal-cell-carcinoma-0 2022-12-15T09:23:18+01:00 0.5 https://vfhk.org/en/publication/clinical-endpoints-needle-free-jet-injector-treatment-depth-understanding-immediate 2023-02-21T15:15:03+01:00 0.5 https://vfhk.org/da/publikation/clinical-endpoints-needle-free-jet-injector-treatment-depth-understanding-immediate 2023-02-21T15:15:03+01:00 0.5 https://vfhk.org/en/publication/changes-key-recruitment-performance-metrics-2008-2019-industry-sponsored-phase-iii 2023-02-21T15:13:38+01:00 0.5 https://vfhk.org/da/publikation/changes-key-recruitment-performance-metrics-2008-2019-industry-sponsored-phase-iii 2023-02-21T15:13:38+01:00 0.5 https://vfhk.org/en/publication/evidence-based-clinical-practice-guidelines-laser-assisted-drug-delivery 2022-12-15T09:44:19+01:00 0.5 https://vfhk.org/da/publikation/evidence-based-clinical-practice-guidelines-laser-assisted-drug-delivery 2022-12-15T09:44:19+01:00 0.5 https://vfhk.org/en/publication/high-oral-vitamin-d3-intake-does-not-protect-against-uvr-induced-squamous-cell 2023-02-21T15:12:15+01:00 0.5 https://vfhk.org/da/publikation/high-oral-vitamin-d3-intake-does-not-protect-against-uvr-induced-squamous-cell 2023-02-21T15:12:15+01:00 0.5 https://vfhk.org/en/publication/copenhagen-actinic-keratosis-study-coaks-decentralised-clinical-trial-evaluate 2023-02-21T15:06:48+01:00 0.5 https://vfhk.org/da/publikation/copenhagen-actinic-keratosis-study-coaks-decentralised-clinical-trial-evaluate 2023-02-21T15:06:48+01:00 0.5 https://vfhk.org/en/publication/repeated-exposure-fractional-co2-laser-delays-squamous-cell-carcinoma-formation-and 2024-01-09T13:13:48+01:00 0.5 https://vfhk.org/da/publikation/repeated-exposure-fractional-co2-laser-delays-squamous-cell-carcinoma-formation-and 2024-01-09T13:13:48+01:00 0.5 https://vfhk.org/en/publication/topical-delivery-hedgehog-inhibitors-current-status-and-perspectives 2023-02-21T15:10:45+01:00 0.5 https://vfhk.org/da/publikation/topical-delivery-hedgehog-inhibitors-current-status-and-perspectives 2023-02-21T15:10:45+01:00 0.5 https://vfhk.org/en/publication/topical-brimonidine-delays-ultraviolet-radiation-induced-squamous-cell-carcinoma 2023-02-21T15:01:55+01:00 0.5 https://vfhk.org/da/publikation/topical-brimonidine-delays-ultraviolet-radiation-induced-squamous-cell-carcinoma 2023-02-21T15:01:55+01:00 0.5 https://vfhk.org/en/publication/quantitative-mass-spectrometry-imaging-bleomycin-skin-using-mimetic-tissue-model 2023-02-21T15:01:01+01:00 0.5 https://vfhk.org/da/publikation/quantitative-mass-spectrometry-imaging-bleomycin-skin-using-mimetic-tissue-model 2023-02-21T15:01:01+01:00 0.5 https://vfhk.org/en/publication/quantification-urinary-thymidine-dimers-volunteers-after-ultraviolet-radiation-using 2023-02-21T14:59:51+01:00 0.5 https://vfhk.org/da/publikation/quantification-urinary-thymidine-dimers-volunteers-after-ultraviolet-radiation-using 2023-02-21T14:59:51+01:00 0.5 https://vfhk.org/en/publication/detection-cutaneous-malignant-melanoma-using-rna-sampled-tape-strips-study-protocol 2023-02-21T14:58:13+01:00 0.5 https://vfhk.org/da/publikation/detection-cutaneous-malignant-melanoma-using-rna-sampled-tape-strips-study-protocol 2023-02-21T14:58:13+01:00 0.5 https://vfhk.org/en/publication/bringing-gentle-properties-daylight-photodynamic-therapy-indoors-systematic-review 2023-02-21T14:57:04+01:00 0.5 https://vfhk.org/da/publikation/bringing-gentle-properties-daylight-photodynamic-therapy-indoors-systematic-review 2023-02-21T14:57:04+01:00 0.5 https://vfhk.org/en/publication/comparison-global-dna-methylation-analysis-whole-genome-bisulfite-sequencing-and 2023-08-24T12:25:38+02:00 0.5 https://vfhk.org/da/publikation/comparison-global-dna-methylation-analysis-whole-genome-bisulfite-sequencing-and 2023-08-24T12:25:38+02:00 0.5 https://vfhk.org/en/publication/feasibility-intratumoral-anti-pd1-treatment-human-basal-cell-carcinoma-explorative 2023-04-11T11:34:03+02:00 0.5 https://vfhk.org/da/publikation/feasibility-intratumoral-anti-pd1-treatment-human-basal-cell-carcinoma-explorative 2023-04-11T11:34:03+02:00 0.5 https://vfhk.org/en/publication/skin-cancer-development-strongly-associated-actinic-keratosis-solid-organ-transplant 2024-01-09T09:30:33+01:00 0.5 https://vfhk.org/da/publikation/skin-cancer-development-strongly-associated-actinic-keratosis-solid-organ-transplant 2024-01-09T09:30:33+01:00 0.5 https://vfhk.org/en/publication/does-systemic-hydrochlorothiazide-increase-risk-developing-ultraviolet-radiation-0 2023-08-17T15:32:40+02:00 0.5 https://vfhk.org/da/publikation/does-systemic-hydrochlorothiazide-increase-risk-developing-ultraviolet-radiation-0 2023-08-17T15:32:40+02:00 0.5 https://vfhk.org/en/publication/rna-analysis-tape-strips-rule-out-melanoma-lesions-clinically-assessed-cutaneous 2023-08-17T15:36:55+02:00 0.5 https://vfhk.org/da/publikation/rna-analysis-tape-strips-rule-out-melanoma-lesions-clinically-assessed-cutaneous 2023-08-17T15:36:55+02:00 0.5 https://vfhk.org/en/publication/agreement-and-reliability-remote-assessment-actinic-keratosis-proof-concept-study-using 2024-01-09T12:50:02+01:00 0.5 https://vfhk.org/da/publikation/agreement-and-reliability-remote-assessment-actinic-keratosis-proof-concept-study-using 2024-01-09T12:50:02+01:00 0.5 https://vfhk.org/en/publication/expert-recommendations-facilitating-personalized-approaches-long-term-management 2024-01-09T12:46:29+01:00 0.5 https://vfhk.org/da/publikation/expert-recommendations-facilitating-personalized-approaches-long-term-management 2024-01-09T12:46:29+01:00 0.5 https://vfhk.org/en/publication/improving-efficacy-photodynamic-therapy-actinic-keratosis-comprehensive-review 2024-01-09T13:06:06+01:00 0.5 https://vfhk.org/da/publikation/improving-efficacy-photodynamic-therapy-actinic-keratosis-comprehensive-review 2024-01-09T13:06:06+01:00 0.5 https://vfhk.org/en/publication/review-mal-pdt-treatment-strategy-actinic-keratosis-broader-clinical-perspectives 2024-01-09T12:52:09+01:00 0.5 https://vfhk.org/da/publikation/review-mal-pdt-treatment-strategy-actinic-keratosis-broader-clinical-perspectives 2024-01-09T12:52:09+01:00 0.5 https://vfhk.org/en/publication/melanin-dependent-tissue-interactions-induced-755-nm-picosecond-domain-laser 2024-01-09T13:02:15+01:00 0.5 https://vfhk.org/da/publikation/melanin-dependent-tissue-interactions-induced-755-nm-picosecond-domain-laser 2024-01-09T13:02:15+01:00 0.5 https://vfhk.org/en/publication/fractional-radiofrequency-assisted-delivery-fluorescent-tracer-dyes-ex-vivo-and-vivo 2024-01-09T12:43:55+01:00 0.5 https://vfhk.org/da/publikation/fractional-radiofrequency-assisted-delivery-fluorescent-tracer-dyes-ex-vivo-and-vivo 2024-01-09T12:43:55+01:00 0.5 https://vfhk.org/en/publication/oral-phytochemicals-photoprotectants-uvr-exposed-hairless-mice-study-hesperidin-methyl 2024-01-09T13:08:30+01:00 0.5 https://vfhk.org/da/publikation/oral-phytochemicals-photoprotectants-uvr-exposed-hairless-mice-study-hesperidin-methyl 2024-01-09T13:08:30+01:00 0.5 https://vfhk.org/en/publication/potential-roles-ablative-fractional-co2-laser-combination-pd-1-inhibitors 2024-06-27T10:54:18+02:00 0.5 https://vfhk.org/da/publikation/potential-roles-ablative-fractional-co2-laser-combination-pd-1-inhibitors 2024-06-27T10:54:18+02:00 0.5 https://vfhk.org/en/publication/prevalence-cervical-human-papillomavirus-and-risk-anal-co-infection-kidney-transplant 2024-01-09T09:15:30+01:00 0.5 https://vfhk.org/da/publikation/prevalence-cervical-human-papillomavirus-and-risk-anal-co-infection-kidney-transplant 2024-01-09T09:15:30+01:00 0.5 https://vfhk.org/en/publication/high-resolution-anoscopy-can-diagnose-precursors-anal-cancer 2024-01-09T09:21:33+01:00 0.5 https://vfhk.org/da/publikation/high-resolution-anoscopy-can-diagnose-precursors-anal-cancer 2024-01-09T09:21:33+01:00 0.5 https://vfhk.org/en/publikation/impact-skin-hydration-patterns-microthermal-injury-produced-fractional-co2-laser-0 2024-04-11T12:45:43+02:00 0.5 https://vfhk.org/da/publikation/impact-skin-hydration-patterns-microthermal-injury-produced-fractional-co2-laser 2024-04-11T12:45:43+02:00 0.5 https://vfhk.org/en/publikation/chat-about-actinic-keratosis-examining-capabilities-and-user-experience-chatgpt-digital 2025-02-25T16:21:53+01:00 0.5 https://vfhk.org/da/publikation/chat-about-actinic-keratosis-examining-capabilities-and-user-experience-chatgpt-digital 2025-02-25T16:21:53+01:00 0.5 https://vfhk.org/en/publication/label-human-papillomavirus-vaccination-and-shortened-low-dose-topical-imiquimod-elderly 2024-01-16T09:20:44+01:00 0.5 https://vfhk.org/da/publikation/label-human-papillomavirus-vaccination-and-shortened-low-dose-topical-imiquimod-elderly 2024-01-16T09:20:44+01:00 0.5 https://vfhk.org/en/publication/line-field-confocal-optical-coherence-tomography-vivo-visualization-morphological 2024-04-09T13:27:40+02:00 0.5 https://vfhk.org/da/publikation/line-field-confocal-optical-coherence-tomography-vivo-visualization-morphological 2024-04-09T13:27:40+02:00 0.5 https://vfhk.org/en/publication/accelerating-patient-recruitment-using-social-media-early-adopter-experience-good 2024-04-11T12:42:24+02:00 0.5 https://vfhk.org/da/publikation/accelerating-patient-recruitment-using-social-media-early-adopter-experience-good 2024-04-11T12:42:24+02:00 0.5 https://vfhk.org/en/publikation/impact-skin-hydration-patterns-microthermal-injury-produced-fractional-co2-laser 2024-04-09T13:25:05+02:00 0.5 https://vfhk.org/da/publikation/impact-skin-hydration-patterns-microthermal-injury-produced-fractional-co2-laser-0 2024-04-09T13:25:05+02:00 0.5 https://vfhk.org/en/publication/introduction-2024-special-dermatology-plastic-surgery-issue 2024-04-09T13:35:28+02:00 0.5 https://vfhk.org/da/publication/introduction-2024-special-dermatology-plastic-surgery-issue 2024-04-09T13:35:28+02:00 0.5 https://vfhk.org/en/publication/anti-pd-1-immunotherapy-adjuvant-ablative-fractional-laser-displays-increased-tumour 2024-04-09T13:42:23+02:00 0.5 https://vfhk.org/da/publication/anti-pd-1-immunotherapy-adjuvant-ablative-fractional-laser-displays-increased-tumour 2024-04-09T13:42:23+02:00 0.5 https://vfhk.org/en/publication/ablative-fractional-laser-treatment-reduces-hedgehog-pathway-gene-expression-murine 2024-04-11T10:15:21+02:00 0.5 https://vfhk.org/da/publikation/ablative-fractional-laser-treatment-reduces-hedgehog-pathway-gene-expression-murine 2024-04-11T10:15:21+02:00 0.5 https://vfhk.org/en/publication/oral-intake-bucillamine-carvedilol-metformin-or-phenformin-does-not-protect-against-uvr 2024-04-11T10:34:44+02:00 0.5 https://vfhk.org/da/publication/oral-intake-bucillamine-carvedilol-metformin-or-phenformin-does-not-protect-against-uvr 2024-04-11T10:34:44+02:00 0.5 https://vfhk.org/en/publication/laser-assisted-topical-delivery-vismodegib-reduces-hedgehog-gene-expression-human-basal 2024-04-11T10:40:10+02:00 0.5 https://vfhk.org/da/publikation/laser-assisted-topical-delivery-vismodegib-reduces-hedgehog-gene-expression-human-basal 2024-04-11T10:40:10+02:00 0.5 https://vfhk.org/en/publication/surgical-planning-line-field-confocal-optical-coherence-tomography-recurrent 2024-04-11T10:49:25+02:00 0.5 https://vfhk.org/da/publikation/surgical-planning-line-field-confocal-optical-coherence-tomography-recurrent 2024-04-11T10:49:25+02:00 0.5 https://vfhk.org/en/publication/ablative-fractional-co2-laser-treatment-promotes-wound-healing-phenotype-skin 2024-04-11T10:53:18+02:00 0.5 https://vfhk.org/da/publikation/ablative-fractional-co2-laser-treatment-promotes-wound-healing-phenotype-skin 2024-04-11T10:53:18+02:00 0.5 https://vfhk.org/en/publication/surgical-planning-line-field-confocal-optical-coherence-tomography-recurrent-0 2024-04-11T10:59:49+02:00 0.5 https://vfhk.org/da/publication/operationsplanung-mit-line-field-optischer-konfokaler-koharenztomographie-bei 2024-04-11T10:59:49+02:00 0.5 https://vfhk.org/en/publikation/incidence-and-clearance-cervical-and-anal-high-risk-human-papillomavirus-kidney 2025-02-25T15:28:11+01:00 0.5 https://vfhk.org/da/publikation/incidence-and-clearance-cervical-and-anal-high-risk-human-papillomavirus-kidney 2025-02-25T15:28:11+01:00 0.5 https://vfhk.org/en/publikation/prevalence-cervical-human-papillomavirus-kidney-transplant-recipients-systematic-review 2025-02-25T15:11:10+01:00 0.5 https://vfhk.org/da/publikation/prevalence-cervical-human-papillomavirus-kidney-transplant-recipients-systematic-review 2025-02-25T15:11:10+01:00 0.5 https://vfhk.org/en/publication/early-results-screening-program-skin-cancer-liver-transplant-recipients-cohort-study 2024-04-11T12:31:27+02:00 0.5 https://vfhk.org/da/publication/early-results-screening-program-skin-cancer-liver-transplant-recipients-cohort-study 2024-04-11T12:31:27+02:00 0.5 https://vfhk.org/en/publication/pre-treatment-topical-5-fluorouracil-increases-efficacy-daylight-photodynamic-therapy 2024-08-29T12:23:26+02:00 0.5 https://vfhk.org/da/publikation/pre-treatment-topical-5-fluorouracil-increases-efficacy-daylight-photodynamic-therapy 2024-08-29T12:23:26+02:00 0.5 https://vfhk.org/en/publication/pre-clinical-investigations-oral-photoprotection-prevent-keratinocyte-carcinoma 2024-08-20T12:30:42+02:00 0.5 https://vfhk.org/da/publikation/pre-clinical-investigations-oral-photoprotection-prevent-keratinocyte-carcinoma 2024-08-20T12:30:42+02:00 0.5 https://vfhk.org/en/publication/exploring-hedgehog-inhibition-basal-cell-carcinomas-using-local-targeted-treatments 2024-08-20T12:42:13+02:00 0.5 https://vfhk.org/da/publikation/exploring-hedgehog-inhibition-basal-cell-carcinomas-using-local-targeted-treatments 2024-08-20T12:42:13+02:00 0.5 https://vfhk.org/en/publication/line-field-confocal-optical-coherence-tomography-dermato-oncology-literature-review 2024-08-29T10:32:08+02:00 0.5 https://vfhk.org/da/publikation/line-field-confocal-optical-coherence-tomography-dermato-oncology-literature-review 2024-08-29T10:32:08+02:00 0.5 https://vfhk.org/en/publication/mobile-health-technologies-interventional-hybrid-study-actinic-keratosis-results-early 2024-08-29T10:37:30+02:00 0.5 https://vfhk.org/da/publikation/mobile-health-technologies-interventional-hybrid-study-actinic-keratosis-results-early 2024-08-29T10:37:30+02:00 0.5 https://vfhk.org/en/publication/urinary-thymidine-dimer-excretion-reflects-personal-ultraviolet-radiation-exposure 2024-08-29T10:41:23+02:00 0.5 https://vfhk.org/da/publikation/urinary-thymidine-dimer-excretion-reflects-personal-ultraviolet-radiation-exposure 2024-08-29T10:41:23+02:00 0.5 https://vfhk.org/en/publication/efficacy-combinational-treatment-versus-nicotinamide-monotherapy-prevention-ultraviolet 2024-08-29T10:45:19+02:00 0.5 https://vfhk.org/da/publication/efficacy-combinational-treatment-versus-nicotinamide-monotherapy-prevention-ultraviolet 2024-08-29T10:45:19+02:00 0.5 https://vfhk.org/en/publication/explorative-study-calcium-electroporation-low-risk-basal-cell-carcinoma 2024-08-29T10:47:30+02:00 0.5 https://vfhk.org/da/publication/explorative-study-calcium-electroporation-low-risk-basal-cell-carcinoma 2024-08-29T10:47:30+02:00 0.5 https://vfhk.org/en/publikation/cutaneous-squamous-cell-carcinoma-characterized-maldi-mass-spectrometry-imaging 2025-02-25T15:47:37+01:00 0.5 https://vfhk.org/da/publikation/cutaneous-squamous-cell-carcinoma-characterized-maldi-mass-spectrometry-imaging 2025-02-25T15:47:37+01:00 0.5 https://vfhk.org/en/publication/jet-injection-assisted-photodynamic-therapy-superficial-and-nodular-basal-cell 2024-08-29T10:53:00+02:00 0.5 https://vfhk.org/da/publication/jet-injection-assisted-photodynamic-therapy-superficial-and-nodular-basal-cell 2024-08-29T10:53:00+02:00 0.5 https://vfhk.org/en/publication/vascular-feature-identification-actinic-keratosis-grades-i-iii-using-dynamic-optical 2024-08-29T10:55:56+02:00 0.5 https://vfhk.org/da/publication/vascular-feature-identification-actinic-keratosis-grades-i-iii-using-dynamic-optical 2024-08-29T10:55:56+02:00 0.5 https://vfhk.org/en/publication/personalising-actinic-keratosis-treatment-immunocompromised-patients-im-pakt-project 2024-08-29T10:59:33+02:00 0.5 https://vfhk.org/da/publication/personalising-actinic-keratosis-treatment-immunocompromised-patients-im-pakt-project 2024-08-29T10:59:33+02:00 0.5 https://vfhk.org/en/publication/metabolomic-profiling-and-accurate-diagnosis-basal-cell-carcinoma-maldi-imaging-and 2024-08-29T11:54:57+02:00 0.5 https://vfhk.org/da/publication/metabolomic-profiling-and-accurate-diagnosis-basal-cell-carcinoma-maldi-imaging-and 2024-08-29T11:54:57+02:00 0.5 https://vfhk.org/da/publication/european-consensus-consistent-use-term-keratinocyte-cancer 2024-08-29T11:58:16+02:00 0.5 https://vfhk.org/en/publication/dynamic-optical-coherence-tomography-unveils-subclinical-vascular-differences-across 2024-08-29T12:00:59+02:00 0.5 https://vfhk.org/da/publication/dynamic-optical-coherence-tomography-unveils-subclinical-vascular-differences-across 2024-08-29T12:00:59+02:00 0.5 https://vfhk.org/en/publikation/incidence-and-geographic-differences-keratinocyte-carcinoma-and-bowens-disease-office 2025-04-30T16:19:16+02:00 0.5 https://vfhk.org/da/publikation/incidence-and-geographic-differences-keratinocyte-carcinoma-and-bowens-disease-office 2025-04-30T16:19:16+02:00 0.5 https://vfhk.org/en/publication/oral-administration-quercetin-and-fisetin-potentiates-photocarcinogenesis-uvr-exposed 2024-08-29T12:17:54+02:00 0.5 https://vfhk.org/da/publication/oral-administration-quercetin-and-fisetin-potentiates-photocarcinogenesis-uvr-exposed 2024-08-29T12:17:54+02:00 0.5 https://vfhk.org/en/publication/exploring-keratinocyte-carcinoma-models-preclinical-treatment-evaluation 2025-01-14T15:23:37+01:00 0.5 https://vfhk.org/da/publikation/exploring-keratinocyte-carcinoma-models-preclinical-treatment-evaluation 2025-01-14T15:23:37+01:00 0.5 https://vfhk.org/en/publication/preclinical-studies-mass-spectrometry-techniques-skin-cancer-management 2025-01-09T11:12:37+01:00 0.5 https://vfhk.org/da/publikation/preclinical-studies-mass-spectrometry-techniques-skin-cancer-management 2025-01-09T11:12:37+01:00 0.5 https://vfhk.org/en/publication/vivo-assessments-actinic-keratosis-microvasculature-dynamic-optical-coherence 2025-01-15T11:17:44+01:00 0.5 https://vfhk.org/da/publikation/vivo-assessments-actinic-keratosis-microvasculature-dynamic-optical-coherence 2025-01-15T11:17:44+01:00 0.5 https://vfhk.org/en/publikation/interobserver-agreement-line-field-confocal-optical-coherence-tomography-image-markers 2025-02-25T16:44:40+01:00 0.5 https://vfhk.org/da/publikation/interobserver-agreement-line-field-confocal-optical-coherence-tomography-image-markers 2025-02-25T16:44:40+01:00 0.5 https://vfhk.org/en/publikation/artificial-intelligence-smartphone-application-detection-simulated-skin-changes-vivo 2025-02-25T16:53:46+01:00 0.5 https://vfhk.org/da/publikation/artificial-intelligence-smartphone-application-detection-simulated-skin-changes-vivo 2025-02-25T16:53:46+01:00 0.5 https://vfhk.org/en/publikation/transcriptomic-analysis-early-stage-basal-cell-carcinomas-murine-skin-following-topical 2025-02-25T17:00:18+01:00 0.5 https://vfhk.org/da/publikation/transcriptomic-analysis-early-stage-basal-cell-carcinomas-murine-skin-following-topical 2025-02-25T17:00:18+01:00 0.5 https://vfhk.org/en/publikation/dermocosmetic-balm-containing-vitamin-b5-madecassoside-and-prebiotic-complex 2025-10-09T13:20:20+02:00 0.5 https://vfhk.org/da/publikation/dermocosmetic-balm-containing-vitamin-b5-madecassoside-and-prebiotic-complex 2025-10-09T13:20:20+02:00 0.5 https://vfhk.org/en/publikation/vascular-characteristics-treatment-resistant-and-responsive-actinic-keratosis 2025-03-12T10:37:32+01:00 0.5 https://vfhk.org/da/publikation/vascular-characteristics-treatment-resistant-and-responsive-actinic-keratosis 2025-03-12T10:37:32+01:00 0.5 https://vfhk.org/en/publikation/prebiotic-and-panthenol-containing-dermocosmetic-improves-tolerance-artificial-daylight 2025-03-12T10:42:54+01:00 0.5 https://vfhk.org/da/publikation/prebiotic-and-panthenol-containing-dermocosmetic-improves-tolerance-artificial-daylight 2025-03-12T10:42:54+01:00 0.5 https://vfhk.org/en/publikation/benefit-sequential-5-fluorouracil-and-daylight-photodynamic-therapy-versus-daylight 2025-10-09T13:16:20+02:00 0.5 https://vfhk.org/da/publikation/benefit-sequential-5-fluorouracil-and-daylight-photodynamic-therapy-versus-daylight 2025-10-09T13:16:20+02:00 0.5 https://vfhk.org/en/publikation/cutaneous-immune-responses-ablative-fractional-laser-heat-and-cold-based-dermatological 2025-10-09T13:17:31+02:00 0.5 https://vfhk.org/da/publikation/cutaneous-immune-responses-ablative-fractional-laser-heat-and-cold-based-dermatological 2025-10-09T13:17:31+02:00 0.5 https://vfhk.org/en/publikation/review-atomic-force-microscopy-skin-barrier-function-assessment 2025-10-09T16:22:11+02:00 0.5 https://vfhk.org/da/publikation/review-atomic-force-microscopy-skin-barrier-function-assessment 2025-10-09T16:22:11+02:00 0.5 https://vfhk.org/en/publikation/prebiotic-and-panthenol-containing-dermocosmetic-improves-tolerance-artificial-0 2025-10-09T16:21:31+02:00 0.5 https://vfhk.org/da/publikation/prebiotic-and-panthenol-containing-dermocosmetic-improves-tolerance-artificial-0 2025-10-09T16:21:31+02:00 0.5 https://vfhk.org/en/publikation/skin-digital-2023-startupsinnovators 2025-10-09T16:20:46+02:00 0.5 https://vfhk.org/da/publikation/skin-digital-2023-startupsinnovators 2025-10-09T16:20:46+02:00 0.5 https://vfhk.org/en/publikation/evaluation-photocarcinogenic-potential-perfluorooctanoic-acid-mice-after-topical-and 2025-10-09T16:17:39+02:00 0.5 https://vfhk.org/da/publikation/evaluation-photocarcinogenic-potential-perfluorooctanoic-acid-mice-after-topical-and 2025-10-09T16:17:39+02:00 0.5 https://vfhk.org/en/publikation/line-field-confocal-optical-coherence-tomography-image-markers-basal-cell-carcinoma 2025-10-09T15:59:47+02:00 0.5 https://vfhk.org/da/publikation/line-field-confocal-optical-coherence-tomography-image-markers-basal-cell-carcinoma 2025-10-09T15:59:47+02:00 0.5 https://vfhk.org/en/publikation/reactions-disclosed-biofeedback-information-skin-dna-damage-individuals-after-beach 2025-10-09T15:59:09+02:00 0.5 https://vfhk.org/da/publikation/reactions-disclosed-biofeedback-information-skin-dna-damage-individuals-after-beach 2025-10-09T15:59:09+02:00 0.5 https://vfhk.org/en/publikation/evolving-landscape-laser-based-skin-cancer-prevention 2025-10-09T15:57:47+02:00 0.5 https://vfhk.org/da/publikation/evolving-landscape-laser-based-skin-cancer-prevention 2025-10-09T15:57:47+02:00 0.5 https://vfhk.org/en/publikation/human-papillomavirus-vaccination-and-actinic-keratosis-burden-vaxak-randomized-clinical 2025-10-09T14:37:06+02:00 0.5 https://vfhk.org/da/publikation/human-papillomavirus-vaccination-and-actinic-keratosis-burden-vaxak-randomized-clinical 2025-10-09T14:37:06+02:00 0.5 https://vfhk.org/en/publikation/dermatological-laser-treatments-and-energy-based-devices-article-danish 2026-09-16T14:37:23+02:00 0.5 https://vfhk.org/da/publikation/dermatological-laser-treatments-and-energy-based-devices-article-danish 2026-09-16T14:37:23+02:00 0.5 https://vfhk.org/en/publikation/keratinocyte-cancer-article-danish 2025-10-09T15:00:36+02:00 0.5 https://vfhk.org/da/publikation/keratinocyte-cancer-article-danish 2025-10-09T15:00:36+02:00 0.5 https://vfhk.org/en/publikation/assessment-ultraviolet-radiation-exposure-preschool-children-attending-kindergarten 2025-10-09T15:44:21+02:00 0.5 https://vfhk.org/da/publikation/assessment-ultraviolet-radiation-exposure-preschool-children-attending-kindergarten 2025-10-09T15:44:21+02:00 0.5 https://vfhk.org/en/publikation/oral-nicotinamide-mononucleotide-nmn-increases-tissue-nad-content-mice-neither-nmn-nor 2025-10-09T15:12:54+02:00 0.5 https://vfhk.org/da/publikation/oral-nicotinamide-mononucleotide-nmn-increases-tissue-nad-content-mice-neither-nmn-nor 2025-10-09T15:12:54+02:00 0.5 https://vfhk.org/en/publikation/trends-incidence-vulvar-malignant-melanoma-denmark-and-sweden-two-na-tionwide-studies 2025-10-09T15:18:08+02:00 0.5 https://vfhk.org/da/publikation/trends-incidence-vulvar-malignant-melanoma-denmark-and-sweden-two-na-tionwide-studies 2025-10-09T15:18:08+02:00 0.5 https://vfhk.org/en/publikation/skin-digital-2024-startups 2025-10-14T09:12:23+02:00 0.5 https://vfhk.org/da/publikation/skin-digital-2024-startups 2025-10-14T09:12:23+02:00 0.5 https://vfhk.org/en/publikation/impact-socioeconomic-status-and-distance-dermatological-clinic-disease-burden 2025-10-09T15:56:08+02:00 0.5 https://vfhk.org/da/publikation/impact-socioeconomic-status-and-distance-dermatological-clinic-disease-burden 2025-10-09T15:56:08+02:00 0.5 https://vfhk.org/en/publikation/curated-and-updated-database-pharmacological-skin-cancer-preventative-modalities 2026-09-14T09:31:08+02:00 0.5 https://vfhk.org/da/publikation/curated-and-updated-database-pharmacological-skin-cancer-preventative-modalities 2026-09-14T09:31:08+02:00 0.5 https://vfhk.org/en/publikation/head-and-neck-basal-cell-carcinoma-excisions-across-specialities-hospital-and-practice 2025-10-09T16:07:23+02:00 0.5 https://vfhk.org/da/publikation/head-and-neck-basal-cell-carcinoma-excisions-across-specialities-hospital-and-practice 2025-10-09T16:07:23+02:00 0.5 https://vfhk.org/en/publikation/imaging-1927-nm-fractional-thulium-laser-tissue-interactions-spectrum-nonablative 2025-10-09T16:11:34+02:00 0.5 https://vfhk.org/da/publikation/imaging-1927-nm-fractional-thulium-laser-tissue-interactions-spectrum-nonablative 2025-10-09T16:11:34+02:00 0.5 https://vfhk.org/en/publikation/assessing-changes-ultraviolet-radiation-exposed-mouse-skin-using-optical-coherence 2026-09-16T14:40:39+02:00 0.5 https://vfhk.org/da/publikation/assessing-changes-ultraviolet-radiation-exposed-mouse-skin-using-optical-coherence 2026-09-16T14:40:39+02:00 0.5 https://vfhk.org/en/publikation/line-field-confocal-optical-coherence-tomography-dermato-oncology-opportunities-and 2026-05-13T15:22:37+02:00 0.5 https://vfhk.org/da/publikation/line-field-confocal-optical-coherence-tomography-dermato-oncology-opportunities-and 2026-05-13T15:22:37+02:00 0.5 https://vfhk.org/en/publikation/basal-cell-carcinoma-guidelines-diagnosis-and-treatment 2026-05-20T14:49:29+02:00 0.5 https://vfhk.org/da/publikation/basalcellekarcinom-diagnostik-og-behandling 2026-05-20T14:49:29+02:00 0.5 https://vfhk.org/en/publikation/epidemiological-insights-keratinocyte-carcinoma-incidence-clinical-outcomes 2026-07-01T15:41:27+02:00 0.5 https://vfhk.org/da/publikation/epidemiological-insights-keratinocyte-carcinoma-incidence-clinical-outcomes 2026-07-01T15:41:27+02:00 0.5 https://vfhk.org/en/publikation/enhancing-tolerability-photodynamic-therapy-actinic-keratosis-without-compromising 2026-09-14T13:04:57+02:00 0.5 https://vfhk.org/da/publikation/enhancing-tolerability-photodynamic-therapy-actinic-keratosis-without-compromising 2026-09-14T13:04:57+02:00 0.5 https://vfhk.org/en/publikation/glyphosate-exposure-did-not-increase-risk-uvr-induced-skin-tumors-hairless-mice 2026-09-14T13:13:47+02:00 0.5 https://vfhk.org/da/publikation/glyphosate-exposure-did-not-increase-risk-uvr-induced-skin-tumors-hairless-mice 2026-09-14T13:13:47+02:00 0.5 https://vfhk.org/en/publikation/intratumoral-sustained-release-resiquimod-ablative-fractional-laser-induces-efficacy 2026-09-14T14:42:52+02:00 0.5 https://vfhk.org/da/publikation/intratumoral-sustained-release-resiquimod-ablative-fractional-laser-induces-efficacy 2026-09-14T14:42:52+02:00 0.5 https://vfhk.org/en/publikation/margin-status-following-simple-excision-head-and-neck-basal-cell-carcinoma-population 2026-09-14T14:58:38+02:00 0.5 https://vfhk.org/da/publikation/margin-status-following-simple-excision-head-and-neck-basal-cell-carcinoma-population 2026-09-14T14:58:38+02:00 0.5 https://vfhk.org/en/publikation/changes-ultraviolet-b-radiation-induced-dna-damage-and-erythema-after-oral-nicotinamide 2026-09-14T13:07:25+02:00 0.5 https://vfhk.org/da/publikation/changes-ultraviolet-b-radiation-induced-dna-damage-and-erythema-after-oral-nicotinamide 2026-09-14T13:07:25+02:00 0.5 https://vfhk.org/en/publikation/comparative-analysis-large-language-models-performance-context-basal-cell-carcinoma 2026-09-14T13:17:36+02:00 0.5 https://vfhk.org/da/publikation/comparative-analysis-large-language-models-performance-context-basal-cell-carcinoma 2026-09-14T13:17:36+02:00 0.5 https://vfhk.org/en/publikation/consequences-changing-illumination-procedures-photodynamic-therapy 2026-09-16T19:57:36+02:00 0.5 https://vfhk.org/da/publikation/consequences-changing-illumination-procedures-photodynamic-therapy 2026-09-16T19:57:36+02:00 0.5 https://vfhk.org/en/publikation/characterising-urinary-excretion-thymidine-dimer-photolesions-mice 2026-09-16T19:55:37+02:00 0.5 https://vfhk.org/da/publikation/characterising-urinary-excretion-thymidine-dimer-photolesions-mice 2026-09-16T19:55:37+02:00 0.5 https://vfhk.org/en/publikation/skin-lesion-triage-organ-transplant-recipients-using-line-field-confocal-optical 2026-09-14T14:50:57+02:00 0.5 https://vfhk.org/da/publikation/skin-lesion-triage-organ-transplant-recipients-using-line-field-confocal-optical 2026-09-14T14:50:57+02:00 0.5 https://vfhk.org/en/publikation/incidence-trends-cutaneous-squamous-cell-carcinoma-carcinoma-situ-and-keratoacanthoma 2026-09-14T13:47:10+02:00 0.5 https://vfhk.org/da/publikation/incidence-trends-cutaneous-squamous-cell-carcinoma-carcinoma-situ-and-keratoacanthoma 2026-09-14T13:47:10+02:00 0.5 https://vfhk.org/en/publikation/psychological-distress-and-unmet-supportive-care-needs-melanoma-survivors-and-patients 2026-09-14T14:08:27+02:00 0.5 https://vfhk.org/da/publikation/psychological-distress-and-unmet-supportive-care-needs-melanoma-survivors-and-patients 2026-09-14T14:08:27+02:00 0.5 https://vfhk.org/en/publikation/longitudinal-assessment-vascularity-actinic-keratosis-using-dynamic-optical-coherence 2026-09-16T20:40:52+02:00 0.5 https://vfhk.org/da/publikation/longitudinal-assessment-vascularity-actinic-keratosis-using-dynamic-optical-coherence 2026-09-16T20:40:52+02:00 0.5 https://vfhk.org/en/publikation/changes-ultraviolet-radiation-induced-thymidine-dimers-and-erythema-after-oral 2026-09-14T14:53:39+02:00 0.5 https://vfhk.org/da/publikation/changes-ultraviolet-radiation-induced-thymidine-dimers-and-erythema-after-oral 2026-09-14T14:53:39+02:00 0.5 https://vfhk.org/en/publikation/risk-skin-cancer-among-patients-chronic-lymphocytic-leukemia-jama-dermatol 2026-09-16T19:54:01+02:00 0.5 https://vfhk.org/da/publikation/risk-skin-cancer-among-patients-chronic-lymphocytic-leukemia-jama-dermatol 2026-09-16T19:54:01+02:00 0.5 https://vfhk.org/en/publikation/line-field-confocal-optical-coherence-tomography-assessment-dermal-epidermal-junction 2026-09-14T14:20:05+02:00 0.5 https://vfhk.org/da/publikation/line-field-confocal-optical-coherence-tomography-assessment-dermal-epidermal-junction 2026-09-14T14:20:05+02:00 0.5 https://vfhk.org/en/publikation/long-term-recurrence-after-curettage-electrodesiccation-basal-cell-carcinoma-nationwide 2026-09-14T14:23:02+02:00 0.5 https://vfhk.org/da/publikation/long-term-recurrence-after-curettage-electrodesiccation-basal-cell-carcinoma-nationwide 2026-09-14T14:23:02+02:00 0.5 https://vfhk.org/en/publikation/u-net-model-epidermal-segmentation-optical-coherence-tomography-images-actinic 2026-09-14T14:26:07+02:00 0.5 https://vfhk.org/da/publikation/u-net-model-epidermal-segmentation-optical-coherence-tomography-images-actinic 2026-09-14T14:26:07+02:00 0.5 https://vfhk.org/en/publikation/repositioning-non-ablative-fractional-lasers-molecular-and-histological-insights 2026-09-14T14:28:56+02:00 0.5 https://vfhk.org/da/publikation/repositioning-non-ablative-fractional-lasers-molecular-and-histological-insights 2026-09-14T14:28:56+02:00 0.5 https://vfhk.org/en/publikation/recurrence-basal-cell-carcinoma-across-different-treatment-modalities-nationwide-study 2026-09-14T14:32:13+02:00 0.5 https://vfhk.org/da/publikation/recurrence-basal-cell-carcinoma-across-different-treatment-modalities-nationwide-study 2026-09-14T14:32:13+02:00 0.5 https://vfhk.org/en/publikation/machine-learning-based-phenomapping-patients-keratinocyte-carcinoma-data-driven 2026-09-14T14:35:17+02:00 0.5 https://vfhk.org/da/publikation/machine-learning-based-phenomapping-patients-keratinocyte-carcinoma-data-driven 2026-09-14T14:35:17+02:00 0.5